-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MjsmwpjWWeTSQYeiv9ZB4kUqgs1HW2f/3avmNv3GpKgQbaIMS5Z/yw6NEThi2hRm EIwaplKoeUpcfUHN6pOCoQ== 0001193125-05-076128.txt : 20050414 0001193125-05-076128.hdr.sgml : 20050414 20050414080817 ACCESSION NUMBER: 0001193125-05-076128 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 9 CONFORMED PERIOD OF REPORT: 20050414 ITEM INFORMATION: Results of Operations and Financial Condition FILED AS OF DATE: 20050414 DATE AS OF CHANGE: 20050414 FILER: COMPANY DATA: COMPANY CONFORMED NAME: UNITEDHEALTH GROUP INC CENTRAL INDEX KEY: 0000731766 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] IRS NUMBER: 411321939 STATE OF INCORPORATION: MN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-10864 FILM NUMBER: 05749439 BUSINESS ADDRESS: STREET 1: UNITEDHEALTH GROUP CENTER STREET 2: 9900 BREN ROAD EAST CITY: MINNEAPOLIS STATE: MN ZIP: 55343 BUSINESS PHONE: 9529361300 MAIL ADDRESS: STREET 1: 9900 BREN ROAD EAST CITY: MINNETONKA STATE: MN ZIP: 55343 FORMER COMPANY: FORMER CONFORMED NAME: UNITED HEALTHCARE CORP/ DATE OF NAME CHANGE: 20000309 FORMER COMPANY: FORMER CONFORMED NAME: UNITED HEALTHCARE CORP DATE OF NAME CHANGE: 19920703 8-K 1 d8k.htm FORM 8-K Form 8-K

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 8-K

 


 

Current Report Pursuant to

Section 13 or 15(d) of

the Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): April 14, 2005

 


 

UNITEDHEALTH GROUP INCORPORATED

(Exact name of registrant as specified in its charter)

 


 

Minnesota   0-10864   41-1321939

(State or other jurisdiction

of incorporation)

  (Commission File Number)  

(I.R.S. Employer

Identification No.)

 

UnitedHealth Group Center, 9900 Bren Road East, Minnetonka, Minnesota   55343
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (952) 936-1300

 

N/A

(Former name or former address, if changed since last report.)

 


 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 



Item 2.02. Results of Operations and Financial Condition

 

On April 14, 2005, UnitedHealth Group Incorporated (the “Company”) issued a press release discussing first quarter 2005 results. A copy of the press release is furnished herewith as Exhibit 99 and incorporated in this Item 2.02 by reference. The press release contains forward-looking statements regarding the Company.

 

To supplement our consolidated financial results as determined by generally accepted accounting principles (GAAP), the press release also discloses the following non-GAAP information which management believes provides useful information to investors:

 

Certain account balances and financial measures have been presented in this earnings release excluding our AARP business. Management believes these disclosures are meaningful since underwriting gains or losses related to the AARP business are recorded as an increase or decrease to a rate stabilization fund (RSF) and the effects of changes in balance sheet amounts associated with the AARP program accrue to the overall benefit of the AARP policyholders through the RSF balance. Although the Company is at risk for underwriting losses to the extent cumulative net losses exceed the balance in the RSF, the Company has not been required to fund any underwriting deficits to date and management believes the RSF balance is sufficient to cover potential future underwriting or other risks associated with the contract.

 

Adjusted operating cash flows is presented in the earnings release to facilitate the comparison of cash flows from operating activities for quarterly periods in which the Company does not receive three monthly premium payments from the Centers for Medicare and Medicaid Services (CMS). CMS is contractually obligated to pay their monthly premium on the first calendar day of the applicable month. If the first calendar day of the month falls on a weekend or a holiday, CMS pays the Company on the last business day of the preceding calendar month. As such, GAAP operating cash flows may vary depending upon the number of payments received by the Company from CMS during a particular quarter. Adjusted operating cash flows presents operating cash flows assuming that each monthly CMS premium payment was received on the first calendar day of the month.

 

UNITEDHEALTH GROUP

RECONCILIATION OF NON-GAAP FINANCIAL MEASURES

(in millions)

(unaudited)

 

ADJUSTED CASH FLOWS FROM OPERATING ACTIVITIES

 

     Three Months Ended March 31,

     2005

   2004

GAAP Cash Flows From Operating Activities

   $ 1,206    $ 910

January CMS Premium Payment

             

Received in December

     275      175
    

  

Adjusted Cash Flows From Operating Activities

   $ 1,481    $ 1,085
    

  


CAUTIONARY STATEMENT FOR PURPOSES OF THE “SAFE HARBOR” PROVISIONS OF THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995

 

UnitedHealth Group and its representatives may from time to time make written and oral forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (PSLRA), including statements in this report, in presentations, press releases (including the earnings release attached as Exhibit 99 to this report and the earnings conference call described in such earnings release), filings with the Securities and Exchange Commission, reports to shareholders and in meetings with analysts and investors. Generally the words “believe,” “expect,” “intend,” “estimate,” “anticipate,” “project,” “will” and similar expressions identify forward-looking statements, which generally are not historical in nature. These statements may contain information about financial prospects, economic conditions, trends and unknown certainties. We caution that actual results could differ materially from those that management expects, depending on the outcome of certain factors. These forward-looking statements involve risks and uncertainties that may cause our actual results to differ materially from the results discussed in the forward-looking statements. Some factors that could cause results to differ materially from the forward-looking statements include:

 

    increases in health care costs that are higher than we anticipated in establishing our premium rates, including increased consumption of or costs of medical services;

 

    heightened competition as a result of new entrants into our market, and consolidation of health care companies and suppliers;

 

    events that may negatively affect our contract with AARP;

 

    increased competition and other uncertainties resulting from changes in Medicare laws;

 

    increases in costs and other liabilities associated with increased litigation, legislative activity and government regulation and review of our industry;

 

    our ability to execute contracts on competitive terms with physicians, hospitals and other service providers;

 

    failure to maintain effective and efficient information systems, which could result in the loss of existing customers, difficulties in attracting new customers, difficulties in determining medical costs estimates and appropriate pricing, customer and physician and health care provider disputes, regulatory violations, increases in operating costs, or other adverse consequences;

 

    possible impairment of the value of our intangible assets if future results do not adequately support goodwill and intangible assets recorded for businesses that we acquire;

 

    costs associated with compliance with restrictions on patient privacy, including system changes, development of new administrative processes, and potential noncompliance by our business associates;

 

    misappropriation of our proprietary technology; and


    potential effects of terrorism, including increased use of health care services, disruption of information and payment systems, and increased health care costs.

 

This list of important factors is not intended to be exhaustive. A further list and description of some of these risks and uncertainties can be found in our reports filed with the Securities and Exchange Commission from time to time, including our annual reports on Form 10-K and quarterly reports on Form 10-Q. Any or all forward-looking statements we make may turn out to be wrong. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. Except to the extent otherwise required by federal securities laws, we do not undertake to publicly update or revise any forward-looking statements.


Signatures

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: April 14, 2005

 

UNITEDHEALTH GROUP INCORPORATED

By:

 

/S/    DAVID J. LUBBEN


   

David J. Lubben

   

General Counsel & Secretary


EXHIBITS

 

Number

 

Description


99   Press Release, dated April 14, 2005, issued by UnitedHealth Group
EX-99 2 dex99.htm PRESS RELEASE Press Release

Exhibit 99

 

N E W S    R E L E A S E   LOGO

 

Contacts:    John S. Penshorn
     Senior Vice President
     952-936-7214
     Patrick J. Erlandson
     Chief Financial Officer
     952-936-5901

 

(For Immediate Release)

 

UNITEDHEALTH GROUP REPORTS RECORD

 

FIRST QUARTER NET EARNINGS OF $1.16 PER SHARE

 

    Revenues for First Quarter up 34% to $10.9 Billion

 

    Strong Growth Achieved Across Multiple Businesses

 

    Operating Margin Expanded to 11.5%

 

    Operating Cash Flows of $1.2 Billion, Up 33%

 

    Earnings Per Share Increased 32%

 

MINNEAPOLIS (April 14, 2005) – UnitedHealth Group (NYSE: UNH) achieved record results in the first quarter of 2005, reported Chairman and CEO William W. McGuire, M.D. First quarter results were driven by strong and diverse growth and consistent operating performance across the spectrum of UnitedHealth Group businesses, with every reporting segment producing both year-over-year gains in earnings from operations and expanded operating margins.


LOGO

 

Quarterly Financial Performance

 

     Three Months Ended

 
    

March 31,

2005


    December 31,
2004


    March 31,
2004


 

Revenues

   $ 10.89 billion     $ 10.51 billion     $ 8.14 billion  

Earnings From Operations

   $ 1.26 billion     $ 1.19 billion     $ 876 million  

Operating Margin

     11.5 %     11.3 %     10.8 %

 

UnitedHealth Group Highlights

 

    First quarter earnings per share of $1.16 increased 32 percent from $0.88 in the first quarter of 2004, and improved 7 cents or 6 percent from the fourth quarter of 2004.

 

    First quarter consolidated net earnings increased to $779 million, up $225 million or 41 percent year-over-year and $40 million or 5 percent from the fourth quarter of 2004.

 

    Consolidated revenues of $10.9 billion increased $2.7 billion or 34 percent year-over-year, and $376 million or 4 percent from the fourth quarter of 2004.

 

    Organic customer growth strengthened for UnitedHealth Group businesses in the first quarter. Gains include approximately 600,000 people at Uniprise and nearly 100,000 at UnitedHealthcare; more than 1.8 million new individuals served through Specialized Care Services; 45,000 more people purchasing Medicare supplement products from Ovations, and growth of 15,000 seniors in its Medicare Advantage programs.

 

    Operating costs declined to 14.9 percent of revenues in the first quarter, representing an improvement of 130 basis points from the first quarter of 2004 and 20 basis points from the fourth quarter of 2004.

 

    Earnings from operations increased to $1.26 billion in the first quarter, up $380 million or 43 percent over the prior year, and up $68 million or 6 percent sequentially.

 

    Consolidated first quarter operating margin improved to 11.5 percent from 10.8 percent in the first quarter of 2004 and from 11.3 percent in the fourth quarter of 2004, reflecting diversified growth coupled with effective management of medical and operating expenses.


UnitedHealth Group Highlights – Continued

 

    The consolidated medical care ratio, excluding the AARP division of Ovations, decreased 30 basis points sequentially and 60 basis points year-over-year to 78.9 percent in the first quarter of 2005.

 

    Medical costs payable, excluding the AARP division of Ovations, increased more than $1.1 billion or 30 percent year-over-year and $264 million or 6 percent since December 31, 2004, standing at $4.9 billion at March 31, 2005. Medical costs days payable was 64 days for the quarter, consistent with its level at 2004 year end.

 

    During the first quarter, the Company realized prior year favorable development of $190 million in its estimates of medical costs incurred in 2004, consistent with the significant growth in the size of the medical cost base and related medical payables, as well as reflecting continuing success in managing medical cost trends and facilitating appropriate medical care.

 

    Accounts receivable, excluding the AARP division of Ovations, were $499 million at March 31, 2005, declining $2 million year-over-year and $18 million from the fourth quarter of 2004 and representing fewer than 5 days sales outstanding.

 

    Cash flows from operations were $1.2 billion for the first quarter, up 33 percent year-over-year. Adjusted to reflect the January 2005 Medicare payment that was actually received from CMS in 2004, first quarter cash flows would have been $1.48 billion, up 36 percent year-over-year on a comparable basis.

 

    The Company repurchased 13.2 million shares during the first quarter of 2005, representing 2 percent of the shares outstanding at December 31, 2004.

 

    First quarter 2005 annualized return on equity was 29.3 percent.

 

Closing Comment

 

“Our focus on the imperatives of affordability, access, quality and usability — applied broadly within the heath care system — has positioned us for sustained future performance,” Dr. McGuire stated. “We are confident that our on-going investments in technology, tools for data analysis, and the organization of health care resources, coupled with evolving partnerships with large employers, health plans and intermediaries will improve the value of services we deliver and help us expand our market share.

 

“Looking specifically to 2005 financial performance,” Dr. McGuire concluded, “our strong first quarter results and improving business momentum are cause for a strengthened forward outlook. We anticipate a year-over-year advance of more than $1.1 billion in full year 2005 earnings from operations, and now foresee growth in earnings per share of 23 percent to 24 percent in 2005, with earnings in the range of $4.85 to $4.90 per share.”


LOGO   LOGO
LOGO

 

Business Description – Health Care Services

 

The Health Care Services segment consists of the UnitedHealthcare, AmeriChoice and Ovations business units. UnitedHealthcare coordinates network-based health and well-being services on behalf of multistate mid-sized and local employers and for consumers. AmeriChoice facilitates and manages health care services for state-sponsored Medicaid programs and their beneficiaries. Ovations delivers health and well-being services to Americans over the age of 50.

 

Quarterly Financial Performance

 

     Three Months Ended

 
     March 31,
2005


    December 31,
2004


    March 31,
2004


 

Revenues

   $ 9.63 billion     $ 9.32 billion     $ 7.05 billion  

Earnings From Operations

   $ 910 million     $ 834 million     $ 577 million  

Operating Margin

     9.5 %     8.9 %     8.2 %

 

Key Developments for Health Care Services

 

    Revenues for Health Care Services grew $2.6 billion or 37 percent year-over-year and $305 million or 3 percent sequentially to $9.6 billion in the first quarter of 2005.

 

    First quarter Health Care Services operating earnings of $910 million increased $333 million or 58 percent year-over-year and $76 million or 9 percent sequentially.

 

    First quarter operating margin of 9.5 percent expanded 130 basis points year-over-year and 60 basis points sequentially.


Key Developments for Health Care Services – Continued

 

  First quarter revenues of $6.6 billion for UnitedHealthcare increased $2 billion or 44 percent year-over-year and $175 million or 3 percent sequentially.

 

  UnitedHealthcare increased the number of consumers served through traditional products by 95,000 people in the first quarter, bringing the total number of people served to more than 11 million.

 

  During the first quarter, UnitedHealthcare signed a joint marketing agreement designed to address the health benefit needs of small employers by facilitating their access to a range of UnitedHealthcare products through OPEN: The Small Business NetworkSM, which is a division of American Express.

 

  UnitedHealthcare’s first quarter 2005 commercial medical care ratio of 78.4 percent compares to ratios of 78.8 percent and 79.3 percent in the fourth quarter of 2004 and the first quarter of 2004, respectively. Advances in medical cost containment continued to be factored into forward customer pricing for risk business, in turn providing improved overall customer value, consistent with the approach in past years.

 

  AmeriChoice first quarter revenues of $827 million increased $99 million or 14 percent year-over-year and $2 million from the fourth quarter of 2004.

 

  AmeriChoice membership grew by 40,000 people over the 12 months ended March 31, 2005. First quarter 2005 enrollment was unchanged from the fourth quarter of 2004.

 

  Ovations reported record revenues of $2.2 billion in the first quarter, up $452 million or 26 percent year-over-year and $128 million or 6 percent from the fourth quarter of 2004.

 

  A total of 85,000 additional people acquired Ovations prescription discount cards in the first quarter, bringing the total number of people served through its card programs to more than 2.5 million at March 31, 2005.

 

  As part of its focus on the senior health market, in the first quarter Ovations notified the Centers for Medicare and Medicaid Services of its intention to participate nationally in 2006 in the new Medicare Part D drug benefit program. Ovations also contracted with Walgreen Co. to provide prescription drug fulfillment services to consumers under the new program.


LOGO

 

Business Description

 

Uniprise delivers network-based health and well-being services, business-to-business transaction processing services, consumer connectivity, and technology support services to large employers and health plans, and provides health-related consumer and financial transaction products and services.

 

Quarterly Financial Performance

 

     Three Months Ended

 
     March 31,
2005


    December 31,
2004


    March 31,
2004


 

Revenues

   $ 941 million     $ 845 million     $ 835 million  

Earnings From Operations

   $ 189 million     $ 169 million     $ 167 million  

Operating Margin

     20.1 %     20.0 %     20.0 %

 

Key Developments

 

  First quarter revenues of $941 million increased $106 million or 13 percent year-over-year and $96 million or 11 percent over the fourth quarter of 2004.

 

  Uniprise serves more than 10.4 million people in the national multilocation employer segment, having increased the number of individuals served by just under 600,000 people in the first quarter. Strong organic growth resulted from excellent new business generation, modestly offset by continued employment attrition at certain large customers.

 

  Separately, Uniprise has seen strong market response to its HealthAllies offering, which served more than 4.4 million people at March 31, 2005.

 

  During the first quarter, Uniprise was selected as the national health benefits provider for the Human Resource Policy Association (HRPA), a consortium of approximately 60 large multilocation employers. These employers will offer UnitedHealth Group products to their non-insured workers, including part-time, contract and other special status employees. The HRPA estimates these employers represent 3 million people who will be eligible for the new benefit programs.

 

  Uniprise operating earnings of $189 million grew $22 million or 13 percent year-over-year and $20 million or 12 percent over the fourth quarter of 2004. The Uniprise operating margin of 20.1 percent expanded 10 basis points year-over-year and sequentially.


LOGO

 

Business Description

 

Specialized Care Services offers a comprehensive array of specialized benefits, networks, services and resources to help consumers improve their health and well-being.

 

Quarterly Financial Performance

 

     Three Months Ended

 
     March 31,
2005


    December 31,
2004


    March 31,
2004


 

Revenues

   $ 647 million     $ 588 million     $ 554 million  

Earnings From Operations

   $ 133 million     $ 129 million     $ 113 million  

Operating Margin

     20.6 %     21.9 %     20.4 %

 

Key Developments

 

  First quarter revenues rose to $647 million, up $93 million or 17 percent year-over-year and $59 million or 10 percent from the fourth quarter of 2004, driven by strong customer growth aggregating 1.8 million new individuals served across the portfolio of Specialized Care Services companies.

 

  Customers accessing Specialized Care Services products are now purchasing an average of 3.7 products per person, up from 3.4 products per person at March 31, 2004.

 

  In the first quarter, earnings from operations of $133 million increased $20 million or 18 percent year-over-year and $4 million or 3 percent sequentially.

 

  The Specialized Care Services operating margin of 20.6 percent expanded 20 basis points year-over-year, resulting from operating efficiency gains that continued to more than offset the ongoing business mix shift due to strong growth trends in comparatively higher revenue, lower margin service lines such as vision and dental.


LOGO

 

Business Description

 

Ingenix is a leader in the field of health care data, analysis and application, serving pharmaceutical companies, health insurers and other payers, physicians and other health care providers, large employers and governments.

 

Quarterly Financial Performance

 

     Three Months Ended

 
     March 31,
2005


    December 31,
2004


    March 31,
2004


 

Revenues

   $ 166 million     $ 214 million     $ 140 million  

Earnings From Operations

   $ 24 million     $ 56 million     $ 19 million  

Operating Margin

     14.5 %     26.2 %     13.6 %

 

Key Developments

 

    Ingenix revenues increased $26 million, or 19 percent year-over-year, to $166 million in the first quarter of 2005. This gain reflects strong growth performance and provides the most meaningful measure of Ingenix results, due to the markedly seasonal sales characteristics of some key product lines.

 

    A diversified group of U.S., European and Japanese life sciences companies executed clinical research service agreements in the first quarter, including 12 contracts with total values of at least $1 million each.

 

    Ingenix secured significant orders in the first quarter from a broad variety of payers and providers for software and database products related to claims data, editing and management.

 

    The Ingenix revenue backlog grew 17 percent on a year-over-year basis and currently represents approximately 80 percent of its 2005 revenue expectation.

 

    Ingenix first quarter operating earnings increased $5 million or 26 percent year-over-year to $24 million, and the operating margin increased to 14.5 percent, up 90 basis points from first quarter 2004. The results reflect the combination of strong contribution margins on software system sales and focused operating efficiencies across its business lines.


About UnitedHealth Group

 

UnitedHealth Group (www.unitedhealthgroup.com) is a diversified health and well-being company dedicated to making health care work better. Headquartered in Minneapolis, Minn., UnitedHealth Group offers a broad spectrum of products and services through six operating businesses: UnitedHealthcare, Ovations, AmeriChoice, Uniprise, Specialized Care Services and Ingenix. Through its family of businesses, UnitedHealth Group serves approximately 55 million individuals nationwide.

 

Forward-Looking Statements

 

This news release may contain statements, estimates or projections that constitute “forward-looking” statements as defined under U.S. federal securities laws. Generally the words “believe,” “expect,” “intend,” “estimate,” “anticipate,” “project,” “will” and similar expressions identify forward-looking statements, which generally are not historical in nature. By their nature, forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from our historical experience and our present expectations or projections. A list and description of some of the risks and uncertainties can be found in our reports filed with the Securities and Exchange Commission from time to time, including our annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. Except to the extent otherwise required by federal securities laws, we do not undertake to publicly update or revise any forward-looking statements.

 

Earnings Conference Call

 

As previously announced, UnitedHealth Group will discuss the Company’s results, strategy and future outlook on a conference call with investors at 8:45 a.m. Eastern time today. UnitedHealth Group will host a live webcast of this conference call from the Investor Information page of the Company’s Web site (www.unitedhealthgroup.com). The webcast replay of the call will be available on the same site for one week following the live call. The conference call replay can also be accessed by dialing 1-800-642-1687, conference ID #4978700. This earnings release and the Form 8-K dated April 14, 2005, which may also be accessed in the Investor Information section of the Company’s Web site, include a reconciliation of non-GAAP financial measures.

 

###


UNITEDHEALTH GROUP

 

Earnings Release Schedules and Supplementary Information

Quarter Ended March 31, 2005

 

    Consolidated Statements of Operations

 

    Condensed Consolidated Balance Sheets

 

    Condensed Consolidated Statements of Cash Flows

 

    Segment Financial Information

 

    Customer Profile Summary


UNITEDHEALTH GROUP

CONSOLIDATED STATEMENTS OF OPERATIONS

(in millions, except per share data)

(unaudited)

 

     Three Months Ended March 31,

 
     2005

    2004

 

REVENUES

                

Premiums

   $ 9,871     $ 7,264  

Services

     902       789  

Investment and Other Income

     114       91  
    


 


Total Revenues

     10,887       8,144  
    


 


COSTS

                

Medical Costs

     7,902       5,869  

Operating Costs

     1,620       1,317  

Depreciation and Amortization

     109       82  
    


 


Total Costs

     9,631       7,268  
    


 


EARNINGS FROM OPERATIONS

     1,256       876  

Interest Expense

     (49 )     (24 )
    


 


EARNINGS BEFORE INCOME TAXES

     1,207       852  

Provision for Income Taxes

     (428 )     (298 )
    


 


NET EARNINGS

   $ 779     $ 554  
    


 


BASIC NET EARNINGS PER COMMON SHARE

   $ 1.22     $ 0.92  
    


 


DILUTED NET EARNINGS PER COMMON SHARE

   $ 1.16     $ 0.88  
    


 


Diluted Weighted-Average Common Shares Outstanding

     670       630  
    


 



UNITEDHEALTH GROUP

CONDENSED CONSOLIDATED BALANCE SHEETS

(in millions)

(unaudited)

 

    

March 31,

2005


  

December 31,

2004


ASSETS

             

Cash and Short-Term Investments

   $ 4,350    $ 4,505

Accounts Receivable, net

     908      906

Other Current Assets

     2,799      2,830
    

  

Total Current Assets

     8,057      8,241

Long-Term Investments

     8,213      7,748

Other Long-Term Assets

     11,948      11,890
    

  

Total Assets

   $ 28,218    $ 27,879
    

  

LIABILITIES AND SHAREHOLDERS’ EQUITY

             

Medical Costs Payable

   $ 5,875    $ 5,540

Commercial Paper and Current Maturities of Long-Term Debt

     400      673

Other Current Liabilities

     5,010      5,116
    

  

Total Current Liabilities

     11,285      11,329

Long-Term Debt, less current maturities

     3,850      3,350

Future Policy Benefits for Life and Annuity Contracts

     1,691      1,669

Deferred Income Taxes and Other Liabilities

     837      814

Shareholders’ Equity

     10,555      10,717
    

  

Total Liabilities and Shareholders’ Equity

   $ 28,218    $ 27,879
    

  

The table below summarizes certain balance sheet data excluding AARP related amounts.
     March 31,
2005


   December 31,
2004


Accounts Receivable, net

   $ 499    $ 517

Other Current Assets

   $ 983    $ 947

Other Current Liabilities

   $ 3,755    $ 3,743

Medical Costs Payable

   $ 4,905    $ 4,641

Days Medical Costs in Medical Costs Payable

     64      64


UNITEDHEALTH GROUP

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in millions)

(unaudited)

 

     Three Months Ended March 31,

 
     2005

    2004

 

Operating Activities

                

Net Earnings

   $ 779     $ 554  

Noncash Items:

                

Depreciation and amortization

     109       82  

Deferred income taxes and other

     16       22  

Net changes in operating assets and liabilities

     302       252  
    


 


Cash Flows From Operating Activities

     1,206       910  
    


 


Investing Activities

                

Cash paid for acquisitions, net of cash assumed

     (19 )     (527 )

Purchases of property, equipment and capitalized software

     (113 )     (83 )

Net sales and maturities/(purchases) of investments

     (267 )     217  
    


 


Cash Flows Used For Investing Activities

     (399 )     (393 )
    


 


Financing Activities

                

Common stock repurchases

     (1,100 )     (627 )

Net change in commercial paper and debt

     227       421  

Other, net

     148       141  
    


 


Cash Flows Used For Financing Activities

     (725 )     (65 )
    


 


Increase in cash and cash equivalents

     82       452  

Cash and cash equivalents, beginning of period

     3,991       2,262  
    


 


Cash and cash equivalents, end of period

   $ 4,073     $ 2,714  
    


 


Supplemental Schedule of Noncash Investing Activities:

                

Common Stock Issued for Acquisitions

   $ —       $ 1,932  


UNITEDHEALTH GROUP

SEGMENT FINANCIAL INFORMATION

(in millions)

(unaudited)

 

REVENUES

 

     Three Months Ended March 31,

 
     2005

    2004

 

UnitedHealthcare

   $ 6,606     $ 4,579  

Ovations

     2,195       1,743  

AmeriChoice

     827       728  
    


 


Health Care Services

     9,628       7,050  

Uniprise

     941       835  

Specialized Care Services

     647       554  

Ingenix

     166       140  

Corporate and eliminations

     (495 )     (435 )
    


 


Total Consolidated

   $ 10,887     $ 8,144  
    


 


EARNINGS FROM OPERATIONS

                
     Three Months Ended March 31,

 
     2005

    2004

 

Health Care Services

   $ 910     $ 577  

Uniprise

     189       167  

Specialized Care Services

     133       113  

Ingenix

     24       19  
    


 


Total Consolidated

   $ 1,256     $ 876  
    


 



UNITEDHEALTH GROUP

CUSTOMER PROFILE SUMMARY

(in thousands)

(unaudited)

 

Customer Profile


  

March

2005


   December
2004


    March
2004


   December
2003


Commercial Businesses

                    

Risk-based

   10,940    10,820     9,370    8,360

Fee-based

   16,190    15,525     14,875    14,110

Governments

                    

Federal

   1,450    1,420 (a)   4,130    4,325

State and municipal

   5,470    5,615     5,335    5,035

Consumers

   1,520    1,455     1,190    1,190

Business-to-Business

   19,675    19,005     19,330    17,440
    
  

 
  

Grand Total

   55,245    53,840     54,230    50,460
    
  

 
  

(a)    Department of Defense (DOD) contract for Optum Nurseline Services involving 2.8 million members and $11 million in annual revenue managed directly by the DOD beginning in the third quarter of 2004.

 

Supplemental Segment Profile - Health Care Services and Uniprise

 

    

March

2005


   December
2004 (a)


    March
2004 (b)


   December
2003


Health Care Services:

                    

Risk-based commercial

   7,675    7,655     6,200    5,400

Fee-based commercial

   3,380    3,305     3,045    2,895

Medicare

   345    330     235    230

Medicaid

   1,260    1,260     1,220    1,105
    
  

 
  

Total Health Care Services

   12,660    12,550     10,700    9,630
    
  

 
  

Uniprise

   10,470    9,875     9,530    9,060
    
  

 
  

(a) Includes 1,375,000 risk-based commercial, 35,000 fee-based commercial and 70,000 Medicare individuals served in connection with the acquisition of Oxford Health Plans, Inc. in the third quarter of 2004 and 315,000 Uniprise individuals served in connection with the acquisition of Definity Health Corporation in the fourth quarter of 2004.
(b) Includes 920,000 risk-based commercial, 90,000 fee-based commercial, 50,000 Uniprise and 95,000 Medicaid individuals served in connection with the acquisitions of Mid-Atlantic Medical Services, Inc. and other businesses in the first quarter of 2004.
GRAPHIC 3 g24791img01.jpg GRAPHIC begin 644 g24791img01.jpg M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$! M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$" M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,# M`P,#`P,#`P,#_\``$0@`60"T`P$1``(1`0,1`?_$`((``0`"`@,!`0`````` M```````'"0@*!`4&"P,!`0$````````````````````!$```!@("``,&`0<) M"0`````"`P0%!@#E189$RLS4FMRC10W1U M=X@9>3H1`0$!```````````````````!0?_:``P#`0`"$0,1`#\`W^.`X#@. M`X#@.`X#@.!U;V^,L9:'*02-X:X^PLR,]Q>'M[<$C4T-3>E+R:J7N3DO.(1( M4:8H.1&&FC"``<>.[NKHC-M0H%K'7TAV"BFYVR;!J_!MMV<;8HU M5B4X<)NHA$EPGD*-X+D%J2.(*&YBL?BX'B>F*^MN;4VH M[?:OVTV!%?KQK5LU7-3P9R:84@K*",,=3QB8JSB(97#:XO9,8(<1!)RJR>X. M2Y480`2A6>(.!<#8'X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X&OWW$_<)ZR=3 M3H"G5<*E]Y;5/D,132.U.R`-BT096%\/=D+!(;`LES0JD3FC@3@ MK:ARF#OPGKZF/#6;D)A"^1G.9Z8['G2^[8\`8#MM1BBB.MS[;D@DL!))/>D^ M%$E%AP`LHHN\+7`666`/@$(``QC&,8]F,8X&PUTM_P`1'[@S]^Z"?J;+>!L< M!:+J7_#A^V]_]ZS_`/YY6QP-A;I;_B(_<&?OW03]39;P-CC@ M.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@?+)^\._B[MW[I-*_K5:G`B'[43.,=Q M]7YSGPQBCMC,YSGV8QC%;K?'.<\"T74O.,]W@;"_2WGQ[$?N#/#V_Z[H)C^B&R[&?Z,\#8XX#@.`X#@.`X#@.`X#@. M`X#@.`X#@.`X'RROO#L9QV[-OCC./'4BELX\4,.NJFN)_H M]U^;B;HO41?"=A>P^NQ=$*&U;.A4?48*X(34N3,".(]0+]*EBD!HC=[2JF'Q_;72BOMP>LZRKIVUG#:L)'#T6U MMXUX8!^AB9:`8DRB1&H"%#VB*S^=]4LXC(?7+$#@6T_;955+XCUGLEWV,VY: M[#W>O*[=T)2E-+$%1@NY97D$45#,,``9Q#S"HXW.)`OR9)6ASC\O`OVX#@.` MX#@.`X#@.`X#@.`X#@.`X#@.`X$%[*ZV4SMU24_UZOZ&()W5MD,BADD+*K$8 MG5I\F!SE"^,#LF$6X1^3L2O`%3>XI1EJD:HL!A8L"QP-'W8OK^[!^J'9`R?U M:DD&R]?S%(]P6BNRB8UGL5OSMCHI4Y_J(D]:L%#I)6L@T6ER)EN[%8L6H,.IK8[43K-DEH);WWMV2V])^4-_>TJU MR'A*_JT3C!`+7!_JVL'AY1E'ECBX*6J+.AZY_2KSCLER%8S MG@RO`3G!!2O!A8,?@SG(39P'`?/8:NM?ZHF5B.P"H3BK M//F[I\-\V?0X&7A-P[A8[)E^NJJ1:UAU@2:_H]@`J M0UO915Z")<9LYUP1!!R$RW!0`.4[RW?$A//PC\XF%A)AO"/]+X%BGQ-M]Y2H M_B"'WM<4<>B2^]I_>5A"?R^\')2/4]5041YL><0,9P'QQX^'`PT!8VW^=^E5 M=YK^G/V#$NM(I*;;&)FDS1.9"QJ0&DY,2.!8T8C0GB`<$O))@:]EW=RN MZ-?]#M`]NH\N/:8//C MX!ZY:N1-B0]>XK$K>A2EY-5+5J@I(D3%!\/,:>I/&6227CQ]HA9QC@8J[LV? M;55:@7W=^O#O6&+`JBI)M;T?,LZ.R":P"0MU>Q=SF3DQJTD.F4*=RAR)L:!I MDRXE<8!(::$T1"@(E^T3+KHQUE;"7"A@*2Z^P67ZR5TUU]'7%;'VT^ M276\H"YJ[0UH=%LC?E#1`(I[ZZ#+-..#C!!91R@&3@"R'*VMW5V2U\[/NMS5 MMD!2\AUWWH7WZQOI:Z&3,BX(*YT54V9X0,PH0BC09"+&, M^(18SC/MQP*I[WW@M*:;WL/6CIP.`-MR,=/&;"[-WE9D?>)Q#M>ZK6N:%AA4 M<8J\8Y'##Y]<5BNSLG.2I%;RW-[2T"PN.PL\X4^`Y6O^RNXS9V"S71/9EFIF M412-ZI%;)U[L564?EL(76JD76FSUN-D?ZZ>Y5,6F!/L+4X6A="4KJZ%.`5*! M82)$`PQ)@+3/B3=ZR9-[^B]X6"4`1D>]$>LJ&D!ZBH"8KU/.>),7GS&8#C.0 M!]N?#'`8/ M#Q\?9P/WPI3Y$8#!Y.1E!P(T�>8L.]LJ4 M28"EW:TXUAF24@#UZ0D2H[!H",E)@F&AR>9@\P(,A#XY\XL8_+G'`QSVCV`6 M4=5*^:PUL:)<_P")0EAR5,J5&J&EK>SD3@Y"3O!+4$02G)C>VXA8C/!Y3 MDRHD!I8@C`$6(-<==1D,J_[?[JWW@:0+5NX;7L-ITNB^QRY:J'9\,BIUS.L* M9ZPB<@`[[%%1!U4SU"%-A-*53G%6].VJ#5@33#T1!9(\B+`$ M.`K7Z[W&LM+.C3?+H+8'3G2^9UI=592O76Z=C MMP)_>NKS6/:*A[C@X'':;ZLR)-=;K:%E@MUUDZ=[1I9(B$L;34Y62`)E1!). M`]'JK7T2[(Z_[[MHMD6_$EN*&[+[3ZSZ]S-W4+"I9JS6&M5=9.JE/3#IZI2Z MJGE&_.XG5X4-&41CTO`(2_W@(A@$&$6R_P#\4-+>./'_``_27L_[Q0\#+3O\ MJ79&']<.M\AL[;EPN2%G[::>$)H`HHFK:^)3K%9KF8W.&)'$L?&,9;"2Q@P3 MXY+-\_XOR8X$F12:R+<_ME[?X==VE\TW?A.N#32&KU,5V1*Z":(O0<"FT*E+ M[8,M9&"^+.@!*.?W/)$@%P),S$GNB9&WDIO>220$`&'312%WY6FL'4Q`NT"Z MGLVYM>=A;N@1ND+`PPKQ)G2QM4U4U$WEC8I:\1)7)Z?@CVG-<7U_$8@8 MR!_$W!4@5Y3J^!^.B3_("-:/N9JK%"7.FZ]K2>;.J*]UZ4/<<>&6C"YOK%*G MJ2PZ-$PMV>X,PMQKHF`H-;F)28T)5(C,)\Y\1#$&(DFI"G;"T\^TL>9U5\%E M[Q++EUMJ22NLAC34ZN#Y5RZ"N[TMKYS6*TQAZR'K'@S*HUO&+*8:CP'D&18\ M>!8AVAT/24R[*/M]==X(E:8C1PK"W[A:V,5"X$QED+CL5JF.GSZKR%$24)!L MS1(E3,X1Z0)4IJ=2%,J6IA9+,$/P"<.L"*1J@^Y3NBU:MVY)Z_3O%3-40 M?5)K2C>'Q]7I?B)3BMGLQW M(MO7V$Q!P`%"LK?6QNE4B9]>UBA<4L_\`N(RU+NC(2I%`C"R$ M_H!VL@,<83]MY"^VEH=2Q=B#3*(3N6OVJ5%@':6[5H(G(89(9,5DEQ0AG)H+7M63WN=[F8DZU7%$=:7'JOH1-9Q5 M#@R)#HDXNENU:X2^?%OD=/*^&*%D@?'E0>Y#$5@2I688<9XF#$+(4-EULPRK M[UH%0RRSO1 M-/0)S#`B&26(*B^W8.OZST5[J^K:K->JYC,5I[?>GMDZ#VER$1Q2A49@8N!LF_3BO?E#Z??(L/^ M0_)Y/DOY:9OE7R^^_$O#Y?\`<_A7C\1_2/'TO'U_SG]?\7`K^V4Z\%UE;C4U MV":^7(50FU53UL^T@^.$AKTFU:JNBCW]U/D)EV.K0^ MH%:4_.,&A4E@++`'%4Y>E:UW?)$YJ%*X]*/)04J!.BP&&CITD+G_`*OZRZS' MW;R1JF"DK-KR>5+.UOZ:(/1WSK6DQMLRY=3W*Q]J M;*@NOTAKA`RN+(X;?1YTAMF,$_LM)*G`^QXTT0N3OC:T%$M+(H+`\&F*CE1A M*?)8>MI3K!L&IZHKW4A\V[?;(T9J64QYU@U-OU1L*.XE\#@TJ2S2NZ/L6_B) MB[(-E+-BM7*X&`\`7S#DSR,1"L`E3:-`<(.2@ MQ4F_0Q)9QU;07J><=YI.&B(=(P+U$L'K_!C9^[Q-HE[?8<-A(%A$N1-S:EC< MY*4JQK\$G+ER4XI,8,(21C/">M[>J"WM^]7J$UBLS=U7%&NGY-%9[*)I#=Q-B\(5B!(`XIQ6%8.\Y).!)2GKBL^);) M';GT-M`R5=M!9U2Q2I-LW9YH%%-*6V7*@A6$\&L5RJ1!:$+>H#9\,29$E0KT M,G4)1M_Z*>E-#D0\A'4VZA%_UGU&VEIS:%[A>TFL3ML*]2:RK+JF/VM%+Y=- MIRU0KC=YK7;))ZK!&702E<,##EDV*H^R.MJ]H%M MK5K)KGS05,VA4U+325#DA>65Q%D!!F!8&`W)X=A-.H&Q9+?.E-_-&Z2Y@D6D MTHO&R8DU*=>(:]M\YM3:A^?9%LM*Y6<.:-RLEIG:R2*R6=K39`&-)A`P4>I. M!ZX@R?K#K]R\UMVOA540^T**/7VTOV=-P*W@[I4CC.S MX.FLFN;GI-X7_&E%2W?7'S%"G*2LK7(0`<6=Q;'UH=&I8'S8./*P`D(110W6 M%**HW(O'L*F6T#U8^V-_T2]T?*%1=7L46H^'MB9PKY;6!UL)!X`T'HXO'7'#KJ(N%FUC5U^D'.%;(WV,HN1BU[D5X'2Q1\9U^8;3/"N*0_+A4C M-;2"6PUY&G+$(P/;6EU@35XW0NO;N@MM)'KT+:NH:XI79^%M]51N/R.G9\Z2)G-IN>`AZHQK"N-;)"F(R9[V6EPH`4(`:\_;'I+5/6AU9Z^:* MK=K%3U7DG[*J`'2\M7E]7IS/ MA9@B0FB%@PHO@;(%+Z1D6'M!4?87=VRK!MA+:QHQQK/51V@4!88#6,7B=CXP MIF]P^9DF4\3SNTK18LD(U#L@5-;`4V^<")K)]7`PA:;P'`#=_P*[^V2<#U<;_N!G_Y GRAPHIC 4 g24791img02.jpg GRAPHIC begin 644 g24791img02.jpg M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$! M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$" M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,# M`P,#`P,#`P,#_\``$0@`*`#(`P$1``(1`0,1`?_$`'(```$$`@(#```````` M```````%!@<)!`@""@$#"P$!`````````````````````!````<``0,#`P0! M`P4``````0(#!`4&!P@`$0D2$Q0A,0I!(A46(U%Q%V$R)!@9$0$````````` M````````````_]H`#`,!``(1`Q$`/P#O\=`=`=`=`=!U9//IAN2V[FUX49&P MT:(D'NV<[*GBFNN2B\9J:3DQ#0L@GGUS^`Z:EL%82=O%S$;.0.4@.%BE[%54 M`P6*^2WB5QMU.?\`'K_?\=JUG2K7+;.LQBV?QEV93YF;,-:FULT6;Q[M@A*4 MM[*U6.5-$NO6Q56:)>LG8!Z##K_FGXVS3/>*[1L"Y@VC1N*EDG*GM.$5;&*^ M[T_.X>F5MI/3]QDHLVAMZHVI,6Q'=AMU12D;A8Z_$.Y M-E68'^:LSB.;"X*P$BC<5@RM&\CW%BAXE@.ZPENE-@@.6,S4JUQ'\59_CEY"&>L53-IM[8N=/)KCW)):),HRDD_P. MH/**YJN9"6S2SAVG2(B1]:R"*8$*=R7W#&.HF`E!*_'JTGC-P[\9')[F/L[Q MG6/XOE]M>93>B+(S=ROMHK-=M58KF09-5FZ1IFRVI\[G)XC*#AF)%5'3]\)@ M*)U#J=!?Y5?(QA3FZZ+F>PP>E<6](S+"'W*"<9)R`3,.N9,KIFF55(QP9V?>4SC]>-%XS4&5IVQ9M'\T8 M6:G>)>FWNOTM3,-X0A*ZVMZD=7+!1M`NTE5;!(U-T6091]G8P3MTCW3(3Y(& M0*%(7&S7ZQXW.1WY*&G9+@MDN-.P>Y\8+=7<>RAO%M8V"(YX\Z!?+%..R3! M=B@]WVF#81:EEGM6M^51ND7+*[H2W3LY+0%FBTUOY%R_*S%S'O&YU4Q,(@D' M8MRSR>\?]#Y!Y?QH6J&ZYW8]UIMMNG&F_P"HYDK4,MY+UK/F#24M,EC\^K,O M)QS\2O.DY9!*-VXJI-3)J(F4"/],\KW#'+L`X\:WV2:Q:7_&YW\PZ4:=ILK(4G31R@H!%D3DZ!(CO+WP4M6A6=?0-#MO(=BYDN/T5DE'CV+ZRWU]M#!FJX@FK=L1Z9F3Y M;E%LS,5P8-E,"Y?9)R%MVH9C7DKA1MFQ4]9/JN*:I6EJ;IM-B[M'K2E*LSB( M,YD(R>1$T)R5\%.F M3(DBZ!2?*1FK"WVY^_O*,(.+3]QRL`>V MEZTRF$#*$`P5$^.%O'AR,_):D4$V@R2_*>48NW:7M&=J,X[!YY1BU74((J"@ MS=OG8IE-]"***]OJ)N@JNFUT$_Q8?%$8ZZ"9!Y9\6B^HZR9">I+EKH!U2^HQ M@+ZDBI'$X?N*]F?@S<:3+MV8()O'D'1 MN1-.D0RBA$BJF`#F*'<0#7/QQY;N-N\B'FRS1;DU?.-E MXO/(BC\@6](;9OC-TE-%P'9Z3(*9E:T'&J4RV2*D15((4X%?QW>-7&7;<'YUVG M6L"PC7K*R\H/+:(9V/1,LSZ_SK6"37I+]A%MIBR04M((1!%WZRR*)5`0`ZZA MR%[G,(A1MF\':$/!]D>DUJ7_0=AKR+Y-A'%RS4/R(\U^1>[\SY7,^./ M*G/*I@]=S[C[7JEKV'Z#C=A'4XG06]$I-97;#L6<<3<*K+&+R7B_Q_BN/3.5AFR5PEU9 M31],L+6!?MVCZ;=+Q\5(/6[D(^,3$AUE`?R,_&723_+ELU=54?1=KX]XO:H; MU-UV[Y:%L'`V^S,[4EH?A1XL-6E9546)J\I7[GKN84B+A5!^4+O^3?K5.07*4R0(JM4%1* M<134`H6;>1%)FQ\OGX_#1L1LT:-[/SE:L4$@21:HD)QOKR#-NW3()$P2(!2E M(0G;]H`!>@U2\-^!Y#R)\-W-OC?S<2D00>\Q>8S;FVD[L3ZJ6V.O-9T.&T&? MGK'/-5V\K%23*.A(M\+A4WI4;H%]7K2$0$'O7]2R'5>4'-!UP4S*A\9#\=>" M6$07,;FALD'9K3I1,NE\57TK%L-S;&)NVQ53AY&H9K#%4L=KGU%R-E&B30\? M(&;)+IA4):+)3;7^)GQ9R8LDFYL47HO&^'+8,DBL_P6'NG-[^IZSN*& M9P0M]Q^#56M>E.BRQ<-K&(RK\=%1P(04&W1:)J"D+A8B(*+J*K& M.H8-XN@.@.@C/8,9R;D#GEBR;<,YINKYI;&R;6Q4>^U^.LM;E4T52.&JCB,D MT'"`.V+I(BS=<@%7;+D*HDS?,VL=80K:M,:6.Q6.X MZ!9(>G.#MU'51KMAT*Q6F:K-7>*,T#+Q\>NV9K&;I"=,PI)B4&WD'`+A7@%A MMEMQ3C%CF86:^0,I6+Q.TVF1D+)W&!FUR.9:-M#IJF16>0D'"?K5%T*IS&$P M]_W&[A&Z_BA\;#FFP^=.>$?')QG]>F9&Q0-(7S2!5J4-/R[5BRDYF+KJC335UX[9E8I7#:RA2,MD)""`SJKT M9LNP=(T054EDC3=%*[C&ZPPLC\R,,ND"@H"?N;H%O<^&G%SDK8*U;]PQ.E7Z MX4^.?0EXZB%G*D:Y/\`N40,/UZ! MTW_C1Q_U'*H;#[WC]!GLEK)JRK4J$:NL8Z`I3JE"D--D:,WB$V"E(EJB*!/X MMY$G9NH_TA\=1/H(B)X[.#"*N'JKU9190YSF,(8N?>-[@;DT+H%0&K5 MP]1TF'IE(BZW'7>MJ/&K\\396D2FU1E&QW;)(XBJ!CCZ`#OV[@(.#(.!'"K` M8:^UO%^+>'YM6=3A!K>E5>JY[7HZL7R!.DX05B+;7",S0D\P7;NE$E$W*"A5 M4CB0_N,-7)RM&G M4HF`LD9O.&6$3%`CI8LU'5&PTQK9(..>(M563!*/93ZDDFQB MH5HX63CF*7H8QA%U@:I(^\KZPE2V<$>&][@\8K=SXVY)9X7CK[W_``0RFZC' MR`9'\A6+76-0'#@AW5:.HK",Q$6QTQ_\9,/L4``$*]>/3AWI&H6C8;9C#!Q= M[^:O'T\8>V7ZJ5#85*F!"5Q3:LWJEJA,YV52(02*@D:T14L/QBE0-ZD2E(`> M+MX\N&VB;C,\C;;B$-(:Y:HRJ0U\G6=BNT'!:A%T5=!Q3&&NT"!LT9GNMM:N MHU2!D2RQ4H5`B29"AZ$R%*$&?_%OQ@#GLCDZG$>E.,UE;^ZT]_2'5GTIU7%K MHY(NFA(EC7%V40080OS'!HJ.3`D;#J.W*C%NW4<,XIX7QRV575431*HJH8P?,.\+H=H3F>/;L7^GYX3O\`H!O^-.6*@!W^ MP?XTC#_L4>@^BUXMBF#CC M4YDW5C(,M,3QBYHV['<]6DH1BAFB5^PY@QG'"1Q$`$X:UU_EML<>QSU]1;-"Z,M'<0\U]QI$W)M&Y*,^BYE[[ MU4K-O37;OZXV8+[(=5I*W.X:A6GLV?29JD),HU5--RO'"@NDPC)(R96H`S7W M)SDS=[CHTU2K!6I0IN-^D6=6C1=BM5*A\FL+.CMI#^"E'2=?TAQ*;'GTNJ"+ MA$R$21=<3"9%D8OM&!97\C.P5ZK3ZSNNT5&0KB.F')I!9*.KTN1)-P3DZ,TCXA[\--O%*IAV1=G(*"@21 MR&WNS95MFE2R-@LLA=:M,K(Y5FH:9(5ZLR%/9<5YN_LI6;QU&.>-]/I$[J3" M::RTPU^/,1;F-;)MGA2(*-S@K6+G1HU`L-DB+BEDKQI6QV6/L#MFQLU;/1IK M,8C5F](:7$)*U3B;97?)NCQTA7&QQ:K#&OA;(#(JJ(.Q!&9J0#%X\GPINT48]:/\`>45* M@9)-NY5#&?O("QHDL@7^Q\;ZS5X14D#I5G:U&1@W.Y/%Y,[MRN^(2+ M(BYC8Y<7)4`L*XU;#);WEK#5G,&G78BSR\R2K1ATWJ,JE"0;K^O.CSJ+X"'3 MD5;/%2(D`A"$%G[`]A,)C&"?>@.@.@.@.@.@.@.@.@.@^=QB/CGOOC/U'=N, MVTA.O+1MMS6-G%OJE3G)ROZ3C3&B:KE%6?9>$>@[?W'0H^,Y`34M*5I)).<+ M9HBOQ+1JZ:R;N5CP[@7#O6*E@%.S[C5I\;-UW?+K M97;7=)4GXIZZ9KEH#720B5G@@FVM-))+U^TFFG[JAE5 M/;(4GN*F``,H?T@'K4,!0[B/U'MT'(Q"'^AR%.`&(8`,4#?N3,!TS?4!_W[C)B0/2(_4.P=OMT"-7:S`U*./$5N+:P\:I)S4R=FS()$ MCRECF'U@G'QO48QC+R4S)+N%!$?^]0>W8.P`"P1%%($BII))@@E[*($3(0$4 M?V![20%``32[)%_:'8/VA_H'0([RL0$C/PEI?131U8:XQFHV"EE2"9U&,;$I M$JS;=J;U>DA)%2":"H/81_P%["'U[@ME*4@=B%*4!,8P@4`*`F.83G-V#L'J M. GRAPHIC 5 g24791img03.jpg GRAPHIC begin 644 g24791img03.jpg M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$! M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$" M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,# M`P,#`P,#`P,#_\``$0@`*`#(`P$1``(1`0,1`?_$`'4```$%`0`#`0`````` M```````&!P@)"@4!!`L"`0$`````````````````````$```!P`!`P,#`04( M`P`````!`@,$!08'"``1"1(3%"$B%0HQ(Q8F&$$RLS2U=A#DZ$0$````` M````````````````_]H`#`,!``(1`Q$`/P#?QT!T!T!T!T%17FD\CHU;D3KKBNQ/\`ROL^S5J!T*[Z+=S1SJZE@C+YA#&>EEW$I(9A;&U7"2@6;E97%CO\` M6).IQOP62S@T@JV4:^R@J(&$4Q#H)6:OM\CD.-O-@G\KN$@E"1:LQ:*7$3F> M#:()JBUE7;Q-%FU:L'[A5V\=))I@/<1*#OUF4E)J"C92:K4 MC3Y5X@*KVM2SV$D9&(5!50@-G;ZN2KN`@`1XX^\Q, M1Y-:%RAS'*IQW*6OB)LA,-UUL[;MD$6]Q-4X.T'7A3H/72CZ$26E7,69=4C= M3\I$/D@3$B)5%`Z?+?DY3^'7'^[\AKU5;_>:_27=*B_X+RN#8V;1;7.:#?:O MF]5@*A`2,O`LY:9D[1;F:2:)G:(F`P^D3&])3!#/7/*[4,)WGBGQGU7C#R.J M^S.HI3&](]!)W M`>7\7N6U<@>/DIB^S8KJ''./RZ<62@7R]1-IKR MZM#D4'"PG;*-G2)D#I@L14B8,1JOD]H62\XLH\?,SA6WR^_;G4+9H.4'A%LA M-1+-2:LMXH;@L$J\4VS*N1F54C;L1N\+HV6:+"HV"G MW"`554CY6.54405*=%RDW?QLE'/4%6KUDZ20>,7B*K=PDDLFHF4*WM_\R/'G MBCRHROBMR2S/<BOWM7=3`QZ:H MHNHXJK1J[2<.`30*NHB$^MIVV0Q]Y0VR&5770T]`M3"DQKNIR^>1R+"SRQ7* ML3'R1+K@HV$ MAF!YJT6FXW&M0B0'4*$8K3S8E, MON6+T[:>,>WYQ_4#K%;QW.+2V=YCH%-:6ZRMI.09L-&FZ-?9@U`@C9XV.7I_(OP/\`&F=V_4E;5/\`LRW(T/\`,+E?<)W,.RG5YGW^ MYDW-QVS^!I`Z1N_O1\LH'80[AT%N/*S?:GQ:XW[1R#NTW"UVO930)VT+2MB< MBTA$I)%M\2O-9)P4#*)MY.Q.VK7[`,H85@`A3&$`$,/W!/E'J?&KR3[+R(\= M7%GDCR]X5,K1:XZ'6 M>*]HG:'2Y\[8X5\L&*N'CE?,\BYZW23SEBH8QV$$XOUAT)&UQ$0!NY&K$1I3!V9`G8A5W M:BG8#*F$0LCYM<"PT?C;8,SNPMODO.2MTG.=,V#.LYI/+3+$D9W-(#9Y M.>;(9I8)U!K/Z13$EU[0"!TUVD;7EMJ97&NQ-LM=&?2T>@_0:IVFD33JNVB,3&0:,SN?Q%^5<^^-=XXVZT>2BXNR'BY^HW>O\`QRVW M,-)JKPDQ1-*J"[HBB"4_4YM$BI2'#V7;8RS58!074*(*#-KQOU9I\8\^IZU"TJ08M44%+7"Q5OMU8GZ*O8%2BY7B9),[>,64,@E(OD MDP=*!'_+^&LG;.;$YY$>1C.'+K\3E*&"<;LQB7J<]#\?N4M)6$&[9 MM9-FU2;E50EGK-,K")B$D8IFJ[)\E\["QT0`0$!#N`_00'Z@(#^T!#H,_'CV M\?.C>+JR<[Y>BTM;2EN2O,:73X@T!*P&1HV;8M9X5K>7$[=9MLUDBYK5HNP/ M9-M.G*T5?R2-5BD&K=R[]N,LP71:% MD5O]'M4]WDG'#9]'&M+FK9G[8]B8YECEZU*TQU#O]%CAAVK M8*_%LX%^Q!8%D@7`IBAI!\>WCWXY<-*8TMF<<=J;BVXWBA5&I[E8:M5Z=0UM M"EJ>D9(]@D*/EMILF4UO\W*BO(D;PQBIH_*]`^D0$A0@+Y$.'O+;D-Y0_&3R MMRW"W4MD/""XZA(:4]D]'RF$G[;'VHD`2'>9Y!/KD"KTA_QJHJ$E5(E4GVAZ M?J/8-!<:Y1SF(=NV35RZB7JK%=Y%N%T$U5XYVO&.W\:LY9*'%)0[= M=9`QRB*:AR]C"&?CDUQ"Y;:!YQ.&/D`IN$O)CC_QDPS4,BMZA](R>,NMFF+0 MRV1A#S=-K4C=&Z:\`L:^L5#C(NHUX1,JO=`#$*4X6G<]N%F7^0SB7K?$[7CO MXFM:E`()1]EBT6KF>H5RAW;>;IUVA4UC_&<257L3)!(%5;'.":QAZ M!ILDN7-G(N/]*QJR\6D].W3-J)7PA#/E9XNH?4O)7P5\D^5%BZ_IN&VV9J7(5D98L8GJ&-R.;WR$JD MRJ=$GIDKEG-KF6J2!5@$7D0Z.0Q^[!F3H)7\SZ-RGLLCQ7N'$]6CJVG).1Z- M\TNOZ/:IFIU&Z8TOB^Q4ZWTUT^@HBP/1F9Z5M,:G$K"P>(1TJ#=^LD=%JH4P M-KN]#USG!7,_Q"]\=+!BF7M--<*TRI[!!T;*HK+KU?'T MI*6^Z4R.9NI>4"#080AW:B9%G8I-P"RCH#H/G1M$E3N&3=^Q56(4CQ`3@GJYR+R M"REKYV]O912-HSO/M1@W%F_EIL^JNH.)MK3!2<30LTAF9->O.BBQ[_*2$I?4 M0/67N'8C=PRF0DYF!5O=7A[)77L/'3]9G)^%C)^&=V60EXVJ(24_T`$M)\G<9C+A;**-I"2L5'JEDN-H0@F;B<:Q$746BK MRPM7;Z+*Y:I3D:DD(*,#&!V!Q*42=S``@O&6M9D]CDI0M]J+5L=:OLUB2-BB M(]TPD[4R2D*]#2C1V\2<1LW+M%0.W9K%(X5#^Z0>W0-M&\LN/TI8(>J(Z57F MUDF9N2KQ821?-XV2BY6/=69FBWGFCU5!:$&<DN?H$4M#:LND+-,L'C M@X(1L,,-"J/)`TY,O#D;LV@D!9PNSD@@R=,(5H=*0,5S+/FTBW41;$$RRJ:Z9BE$#E M$0\EU#-#E0.30Z,(0$)`05DXHAP%RW+W50`0$Y M2]`L4';5T*Y6SENX,U5!NY!!9-86ZYD$7145P3,84E1;.4U`*;L/H4*;MV,` MB'L=`=`=`=`=`=`=`=`=`=!\ISPZ1;^+B^;,T\:.$6Z#:HUHWN)&*)IF`R?F M#HLK&E`0^YVTAJ&N)R!]Q3*)@/U.7N'T3?%[#.8KC58G#@`]N7Y(J6I;\Y>4&KXZCXY"(I+G$0()._J`$A*^,ZX+P=EKT;L% M>*WGF=P@%)64KEX>3#Z"NAM5D1RE4FQR2)E4G M1D$@N&=LV"WWIQ$Z'!5RF:4M*RUF1=0MC>6-O)2N#R& M$2<`DG&VJ(K-BI-@ATHIX[:2;58R:[%4">H5TSM@2]QX(VF5L4S.U*]9[70; M/=D+34%LY?JB>)WIO?VEK;WJQ%/8:P')#3MMI%ST$S6P&2M4A+.[2S.NU M;JLE$FHKE,J1PN?V0Z]VX1:/K=D5LVJ:A095Y.6"J6V?)&9HMWC5:.6_Q->S MRNKO;$87&>GK>@*$>B^(H\=OFIUC`!'ADFX(:X^/FR+7*#;4V2SIM4[!GVG4 MRY3LEG[$SJG#:[_*V]O8:9%-IUIZKVX;6]5%J].11NW&*[K@8JR29`Z%1\;B MR4C8)/1[_5[@I8BU!C(-T:,^(DM&URS<=):<,B:6M,FG"J76-P4Z"S.-291D M:6531:M_88D*N$P^)^66;(,0JU7O3L9+0':LG/W>55,U5>O9B3>*!'MY)RQ< H.V3Q]7ZLVCHHRR*ATE"L"F(82B`]!(_H#H#H#H#H#H#H#H#H#H/_V3\_ ` end GRAPHIC 6 g24791img04.jpg GRAPHIC begin 644 g24791img04.jpg M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$! M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$" M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,# M`P,#`P,#`P,#_\``$0@`/`#(`P$1``(1`0,1`?_$`',``0`!!0`#`0`````` M```````)!08'"`H!`P0+`0$`````````````````````$```!@(!`P,#`P,# M!0`````"`P0%!@$JD_"9(M&R>]0MT695JGJ44Z MOZQH9QGAR5A7ZN<`R&DJ.V/*AMY@*NH:[AFC]2+\A&@FEII,2RX'-!G..BM` MR2)A4M[4>I3G!,]J=%348^G5*]FAZ#R%SD^)AHL``%6T^V&S6Q+GDWUC6Y=. M5L5@N,CR(9Q26(&*I.%L+$,6>F$*I&7C'_:6'^F`R&@\._CG0D`+'KHB7J`X MQW."^P;5-7F#Q_N9/)G!`2C.OUZEA!P+Y8-%D]*C`XZIW7:].FI!^N37LLEC M[E5=,%B4M#NW+209ZEF8SCIP-O:[E#[)60P$O8"H MO-6-4)HEC&D6#,DD[!9F23RRE)1Y)87 M[P'`:(!1)!)0,B&,6("C#0F9X#@.`X#@.!Z5!@R2# MC2B#51A1)AA:4@1(#E(P`$(!!(E)R=.$TX6.T.3#``QG/ZA8QUS@.94O:F^/ M,UL!L)I[5L&G&N.MNL]HH8%L%))TFBH9-)O33K4#NV2%A1O\E9Y8>EG<0?FE MGCJ,3K$7,U'ESD*Q6C1?:[T&Y&IU_H[/=+`UT\6$$KEOUTUPFCC`+=W*MW[H MF\)GEZE%DJIW&ZOCD>D$L-M-)P,XL-*)3Y'_(&P^5SQ::R2F9T&CUWW;J4Z[WN.UQ5# MXUS4AO%5DT?C8/))9.YO._6*;)*V)#R7!G(:#510,EF%EA[@F!T]3Z'W+-:XJJR8+'JCMZ6UF8^S-/%4K2^!0KQ.$5*1EMDN M>7K$D501>VN3H5[3XU*:N"6F6JL?JX$I'`!QY^:BA[-BFGN MI'F,K=JRW;4ZL;%(=L9TEP''RI=37W+H\X-T`D1IF<+%*&JFQ!$(TH)%@113 M4%R%G&`C'W!TUM]]R_833B);):;GUB\OMK53&+3JX-OJI&&!F(Y"RI7[+3*E M$(":_)5J$HXQ(?@@.1$+"A!&'](L<"%/Q2;W>4CRPZ@SFT&=_P!9]:WPF\[& MA6;F45>^VI9H-6-*"LAC$XJV$YP.-\[Z:>S57KB^;#:4;$+J;>]MU\1=V>M1QL]TF3"B>,4'&']G>9O M-AN,%6GHDA3I'&D*(T&5BOUR,$K@MS7?RC[6:P>0;R(Z>>1VY:KNJH=/M3L[ M>I+[K^H2*@D:**HT==O!\9/A;?)'AK<%+FW6.6D3ILJ#U0G-(6$M4:!5V%A) M+J9--V-U];6#:QZMQHU4%?,7+L37JD8O6\+L9!7];R$LURK!?>\DFR14_P!C M2Z4QXY&Y.Z6/*(BD0E*O9)QY.*$M&$,]X>>_2(U5E)D9X;R MP:T?.CL9--/MAZ%4:;Q72NR8##'Z90RUVN7)K=DK"Z0!`ZJ;5EQ+0I4GW7`)#83Z/JLI(6:E+6@^$G4:V3EM[ MZR6]1MP[)0FC["UCBVO3S"PQI!+$;HZB/BEP/5C2F9R1P3L["M+PX*2&LKWW MH&_&Y(&8G`&[23?"X=R?(;>NB.GDB8*LK+3-B8E.VFSKI%$<^EJNT)2I-(8* M+I**OQ@86UKVP+>O$^R%[3.Y1)[>>C3M_>$*H0:/^3'=W<74^WZ[\=;M8E67 MF1Y#6MOKJD;ID*-)4MFU))))-&F$O\!NMMK[!,46P^UVEV,;(]+VA#'7!H/, M<#PHW`YL!@T-1O&CY7I-I]IQY%G?8"LZJ>IAJ5M?%]1ZBK>A8Z;#G#8+8>7/ MDT9PMR^6/IKDYKQS2PBU:X"E022FCT<(&2C0@*3%I1!.9>`_(K1^G]L;5R_: MFK$=UU#3\SO624:E)>C7(-^N"(29K-;`2<,F3G&'YPN MPV%EY]C@-0:8\X3UO+$O'W5NH\*C,+VFWCBUD3FQ\V-E;,H1J56%'/S]#[5%OS(YMRQ7[7) M9J1<`8!E&A-AP'`ZL;RB8RQMJ]$E69/2*R1A$0<`! M@!8R'&>!SF_QL]MV.NJ@W/\`%O6['$GN[0!(K.$YM1)QH`C4D8,)"(8<9% MU%CJ$<.\5/*]QO-3YL=<:FE<:76=:GBTA4=K5G)DS.2*861`5>IE@$5JE.$M M`6-Z?\Q`:$9'7N(R=WG8`6`8@AMUXF-Y_"J[Z=5;4&ZD6U-UOVYUTB**H+VA MFS-;PNO92YR"N",1P,P`[39D2@?%TB;F\I0XIQG?)HW3*@D\C&`EFG!;7FLL MK3>:>#+;26:;4Q7E,T5-[\H='7E@1.OHY33)M2],D_B9DHL2OXJ0Q1A^F449 M#"#6Y(_J$X\._P`'55IL\,#AI_K"YLCJSKV$&N]-^WB5M M&$R:MXX$625J0XQ'Z!``=,YP+M#C'`Y./&?1U8[SVU_*+U/6?R-5)XYM0[;LN3R]K!V*I M9%R9@6-4?2#,>`1.+.(P.#X[Y+"C:V].8,PS!HB2S`YZ[ML9J9A8 M+2Y24>DB)7,WF02="8['226U%-QD+)$K<%N507B5NZ@>2LM4F9P#O'GZ MALK_`"TY-'6O5325&O?V-$OQO_43Z%`M=D"58-F:X98PG%XPD/4`4":6[UR\ M*%.`Y))]0'>+'<'J&)=3+*=?%CY2_+#5LTBZN=2[R%3R$[-:)*FTX:YAOM/* MIE:CBYQMMD:("@!R^#.MCY3KT1'J.2H+:;E$0?DTCO#%&\VGM@;,^03QS44I MEYEF[8MU^I]U=[)8"R-9<)+&G^K'FQ:=U0P2*+T\B=Y37$.7WLV* MY2R,3.8K<9*U1Q3("709B0LW!C:D6"*[Q`P'(=A]-?R!_$7L3K8EL6R=G*?K M3[BAV4%JT%<"H.9RS.#HVC02F!'P$YM7+K-0*!FG)2A,Z1S3.R8>,`#G(Q%! M"`?<)LJC4'R!^/KR>6;HZ"O/%;8]*/>MCI4[E3S7AMH6,BDUBGUM.YO3J2.% MHJY=YV@E;=,TS(>E^4`5\@C,SEX"--P)K7O9WP"3IKB[!1-::2[C7%8:M$BI MO72FJEK*P[*G4N6!Z-A*M@,BBP-:,[8$P:AW?Y"6VM["W%*%"DP."\EB"/JM M_/3;7DG76HGIV*/&LU,5_9E6Q%I)3OJ1SMNP6J5L%D2M8NF$D0)\(86G][6R M8G#:R&&"&B6JB5"]0$8/3#IC\?PS3-)M71''JE)F*6@X!*%JM4N5FX+:""PC M4K5IRA8K.R`..XPTP9@\_40LYSG/`V40SR$.B)"Y-DOC+BWN`98'-*X)5#>\A,;U;J`;:L*,&G5EC;4)Q^!`%D.2BA"Z],9X'T/C^Q MQAK4ODC>&QA9D>4X5;J\+DS:W)1*U1*)+A0M6&$IR9G`,AF2 M+Z@:EPC$E#"M7M=H>&9QE?"I@&+4I6T>Q*X:Z")&YQ.2X:(TCP^QIP&F+R>A M5>JE-R`.1`STQP+0QKKHKK>>AMM+0&K%)N$:,$B:;"9Z@JR"/#,<\ISVHQ&T MR)IC;ZDAU+5-$ZJDOROW%64:KF'L5?/WSJ8I$]_,PQK9TL M<<_F4A`"E7KIA^X+!@)G=C&,<"SH1I]J364G:)M6VKFNE>S-@PIPQ2Z#TE6D M3D[+A8E.0J\-+\P1EO=6X*I$H,),P2:#`RAB"+J'.<<"NW#K7K]L$%D_-U,5 MM:2F+G&*8LZ32(,KV^Q52=T]=3%I`K2#>XTH/QCH,Q"H3C'CZ"SG'`HT!U(U M@JX,AS`:!J6,JI>S+8[+79%!F`Q_E4><2!I5[!)I$L1*7U_9%:;$)(^@BI]CRZFZYFE9T[ M$6P9J-$6^3=Y8E`')G8,]Y:9O2+"6LH[!B<*@2TO#<>&=]<_%YKI5T*/0V[7 M57W7,9!W+'P$AK>'FUQ%E"HX2PYGK"OQ,2>,Q!K1*3,X+/1H41HNW'H%(4V" MD1`;BQW6C72(P.2U;&*&IQAK6:^IF:0%JK6'(H?,A'``6<9+8Z2SA:I,:<64 M$(QKBCQ#P'&,YSTQP*1`=2-4ZHE#?-ZMUDU\K6:-*98B:Y=`*8KB&R=M1N"4 MQ$O2('^.QMN=4B5:C.&4<66:$!A8LA%C.,YQP*2CTJTY;[(_,2#5'6]%;.%_ MRP;+2TC6J>=A=_6]QEW!*RHT%[`[Y/\`UY58/PHR+ZY'P,_2:+QJ:,#K%)C' M6*61=]1F-[Y&Y,TH'Y@>4!O3U4+JSNB=4W.*,WMQW%'%C`+I]<<##U/ZI:OZ M^+W5UH;72C:7=7PL1+TZ575$%@#DZD#-`<),XKXLQ-:M8D]8L(\%&#$7@6,9 MP'&>!^;1X-VQ85!KN4FDC**<=@J09DXS`Y`$2UJB%C1]S+ZBQC'H?HBZ3(9$GT)UO)8!($LF6ZWP1RC@WG!^6PAS?(2D=H^8ZA3 MEFJ?8@-7$"/P``C,%]V,8SGZ<"QH1JA:-4PIMC5<<9Y.0T'R5>`^0@<2D2TU2\."K*DK&#/5X&*0Z!6:&NS80 MHL-@0JE!H`%D8R6G-R;@L M9^<@X%,?-%;YD*20('F>1A[2/KV>O)1OL^FJQH8W`%F1R;-LZ;69O@K22JD2 M2),YL:$B6F*>]*(LP2\10,I,A]ZW1*\F)_$Y0&XO^$)A9B494IGUJK+*ZOCXT.V8/^<+'.).,^=H3) M@-4P*4K"%LCE2UP9X"7;#7/01QI=D$6C*9V.3QAC(90$X0M*0!9FAC)%&J+3QC`["J2F*VETN6RF2H71(KJ-_FCJH=$Y)D7D2F:))0WS MI24#*E8T+VQP2)5Y2@PX/]L+25:AW\RKUPH'8#`V-_Q,FCA(5MC6D!0^()/$ MI+&F)Y>2S&QX"A=:?+>RBF@HLU2)W+*R<>I1'X!T"KU)KW?,>KN&/RTN+$SZ M/6%$;,15_+K!FSTSJEZ2F7VKI8IDLR5,LD<6.32EPE![PK(0HW%$!2F"4$XS M)YBD`45/I5;;O(L+I?/(Z%C+5A7+66*RFS69ED#R;:.9<-]+CJ96C31-.SUN MK'#6]K*5.!)34C(QD_!>0DD!BI#IKM6Y-TC;2YJT,"A$]2%E*D;O9MBJWB:( MD\:8$E;3!*2>T29KC!57OC<;EN)"2;62DRF6+F]S?(I#X\0Q+,8?'8:@MUD5E*E;BH"64(I8A*$`_MR` M(!!EN8[+-6O4@RP;#IG:*0!P6B!#;_$WJG"M%!*L\P2*-V0\-R<[\<2MO+$% M.%2YA*:G4!?KE*@&B-2DAL%'+)KJ8MQ+O$I]"Y2U*"PFD.<=E+&]-YQ0L=0F M%+&UQ9F'G``Y%G!93@Z MIS33,XQ]`A#D0L_3&,YX&G%QQ./US4K:6::LA\=[#T1^[]][K_C>S]OW>IZGZ.SKW?3KP(>;@_P#B-\ZX M?D/]I7S_`*@_EOL7V7O?7^OJ_)?B7Z^Y[NO?ZOZ^[KW?7KP*)4O_`,,_G$WX M_P#VN?+^J'T/O#WWM_4[L=O?^3_\;TZ_^?TX$O4`_'?VN@_%GV7]E_J^,^P/ @@_M?^@>_V'V[_BOZ=.OI_P#3@7IP'` GRAPHIC 7 g24791img05.jpg GRAPHIC begin 644 g24791img05.jpg M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$! M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$" M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,# M`P,#`P,#`P,#_\``$0@`10#(`P$1``(1`0,1`?_$`($``0`!!0`"`P`````` M```````)!08'"`H$"P$"`P$!`````````````````````!````8"`0,"`P0% M"`L``````@,$!08'`0@`$1()$Q0A%18Q(A<*04(C&#E189%VMSAX.M)3D[,D M="BX&7FY$0$`````````````````````_]H`#`,!``(1`Q$`/P#OXX#@.`X# M@.`X#@8QN.S@TY74@L4<`LZSP1X*`8X33D0-GEBO`5[FC;19C\4(5H3W82#" MOW"@(#,#`F*,'C`LA[V*!6-.\1IBU\5*U\42I M7I(P/#S,"BY/DR,,L=IT!D-[MR=U(#I!!D%EVA6E\S6 M!F`>%$DE-,5BJL5IKQ`SA;)RP%.K-P(C(B3>\1>`= MK*P$C`CBNP1F!]LNZUV[#T)3)TW^M-<'A2W255*(ZG:&&7 M-R&1.,0<))!UR=U<5"YF12=J-3"]Z0@4B",DT!0BS>H0D0X#@.`X$>$4\G.L M\QWWF/CJ9S9OF](9'E+PM=U$=3E5XX.K;'FR7/<1:WX+J8Z&R%GC+N2K-R:@ M*1#P`XLM0,TKL$$A_`5B:R(I'DP MAN<+9$3_`%;'')Q;YAF>.2R0JH\ON)L%T6Q=F3/Q*!PRB,(,)()5A++P'`8L M!ND^X19H`F%F:M;!`&6,.!`&`532W`@B"+&<""+&>F<9X&A*?R/Z^:`Z5:5* M[]CUW)HT\ZHZ\*$H7K:/F;U&K6)QN6ML=V&N!.Z5+"+PF#;2%*/]AK*6K:Q8XBED1>[ MQ<4BI%%ZU5ND?7!5X0+7'Y@!-C)XB<$9`:(-KJHW9I&_=7S=M*#,F5UUT6TN MZXN-US$7!XM)2\L!F"'J$$5^I$@=L3EO4Y],3>/(!&8R$PL0R3"S!A&3XXMG M?&;,-@-UUVF^K]U5GL&F8WBUMDD$CK)S89A)7%FDKP2YPJ,Q1VG+VI:)6HFB MI8,;"C1-1!SFHSD>/4[EDOG5OUQ)678*F9;1L3-D\_9+FI]9$GY M,X"E43A33`&:(H7E]F\@LR3R2:MZ9J94C8:J[X=P9RI'RB:[W#?2?6 M"0Q6]=<;\>6+ZGA-9;/U2Y5$_61'L%JSQN<"-5KW5K?!%IT!YF4@E!*_M(._ M8=2#\%A0=LO+;JKI9;S'2MYM%[M,KE"EA211W:*5EKE!)8<_9:0`!%IV<6AC M,B$SJ'H@ER"C4'#0'BR6=@(NF,A577RL:I-&P,9U[4*+%-J8;*U#H0Y2:3,[Z'#,>K1MYS"2_#"V#<`K<^AP-*=;]JO&;; M/E0=2(IJI?-3>1&;P=]:Y5)[CJEUKQ]+AO#$ZSE6A9GU^A;6B)+< MDS/[IP1@*+$HR2(61!(S>._M1TU;Q.OC%";KV%ODN*D3R1U+KA7F;%D\"@ZU M1A*V2JPERYXC42AB!Z4]0H2%SF4N6_`1"<8!`$(/G67R(ZR[;6/-*?J-\FN+ M5K&+))-:=?3FMYI7TGK-0ID*V,'1*9H96T-H6^9-[HA%ZZ(H9^`D#+.",91@ M!9"C7!Y':+K&Z'#7"'Q>YMD[^CS&7)YM4VL]>#LJ0US'5&$V43I8CNL=XU"X M=EQPK*]ND6NI;@?@P&0$9P87D89"UFV_UTWBAT]!6+HN<%L,=W*NKIJ"QHLX MPZRZVD!@5K>Y0^S*\D:A5X+-"4<9DLW`0\2.Z5URQR*/. M:N2S&11Z(R!9*(W#WL$/RG+=UBF.+NZ22YNB;?8LY1)%\+8SP$O#PL"I/9$! MB[*PQ*2((;B\!P'`!"!Y4/\`+L5GC/QQFF-$,9Q^C./=U%GIG'Z?CC@;P>)FH8C7WB1I M$A$W)EJVV:&6VA8KFM+]TLETCL*,J%:LU]/4=YK@6V1[V;*E`9G("&MN3IP8 MP64$.`CN_*F+%0]/=C6T1Y@D#?LKZB))D6Y*UAMGEGO:DY&I2&KE"HT*@1@18P$(SQ?YKDO^?7K/7^?_`*;A_;_+\.!C M"^-J[^\,7E2V[ORW*,DUOZL;MN4`>V^PF4S")2WD0Z/E-K*S1Z5KR#8X1(84 M8X+T"F.N9Z`2U'A*I3G`!\1A(5JGLSI)?MT[D>3;5>T,K9\+3EI:;EUQED2^ MD;#:G6G!RR4LUCO99CN=\T1O3&0B8AJ&X"YOQ[`G_CLF"]'`17^`'=*,U/7^ MV5LVM5.UMSW#L!?*:532?4OKI95W(%(28T0^^QD$JAS6Y)FYYS))BZJO8'#" M860I*,QCL&#H&=]:GRZG#\P)*-CZFUKVGK[5W9^%"AUE/UEZ_P!E5>R"=VBG M&]=AZDQ4E84B)L-*LF!)L)E)XPB-&O-P#/50+`@ZV>`X#@.`X#@.`X#@.!QS MZ3KF/QN>>3<*O-EUY-9Q;;%)8CM1%BRX\IEADN+F]IM]IQ0@B2KQIVCO6IU+ M@SFYR;CT7M#A(/M,.*P,)_/)3L-7D&U*N*N6Y^:)=<^Q-:32C:!J&-NB%VGM MJ67;4:YK6M$M>PK71?@OV;:V)SE)YA98,YX$7GG/?*UH#PZ1 MG5666;!TEM(8OJW#(K"%$C;"9=,4]9R&%(7Y^8HT8IP]*F%$DB:PXU;Z.$I7 MI9`(S!F0AR&]_BBMNKK,\5VO[57MA0Z9N]<"R$._P"5TO\`HN!ZW[10ZPR^W)"(Z--:AF5!6+`=Q"/TNIXB\"!D06/ MX?=D]?Q>:WR8R,=RUPF8+[D\^(I5Z7RQG;6NTE*J^!+4"*$+EZI,GD"]V1*R MSD2=.(9ZTD7>0`P.,YP%M,6P48UK_,T[%3RP%N&*LW_I6L_FBL.2X_`6^.VM%_'3KJ[-E MAVS,[#?+/G*:*K"']+6D!/8RHB@FLS5-1BLAD92&=]>',0C\@R),WX[<9R>1 M@P,1_F?993L+UXTXUMC<]B9\WK"=D*3:Z(D#8KFC#7[%4ZR,L[\^L"908XM+ ME+3&J"RL*Q#SZ/?@`^T.I?7Z^J1O"JV*:TY;=)@7E(\^H8F6A(4%!Z]X`],]`Y/<[8:RB_,XAN/%]U-^$0 M:N_#S-IYG<<_#G,Q_=_$S_)<3;YA]-Y,^G.OX_/5)F#2=H:2=;6#5:?(MQ6FMW`*JJH5+K MAC$TA1M6-JMO//9&MTDHE#$]98"#!`0*$J@X!)(21%EA^OA0DB7Q@;-[9^,_ M;)^;:R?)-,FFS]=YI,EI$!A#8#9.A]5Z^<;2V%M2' MU/!FPLT0WF6.A:0UQ/)!Z@FV/M!6#WJ3/)@,]2T+]260K MRK$F*3Y@\.:C]HJ5C(3@#\,!+`$.`@"``0AP$A_`O`@5&%@P')I/IF9QC&.O3@8_ MIG3/4O79W.D-%ZW4K5$B4)3$)TD@],WT0#"7Z@Q"Z=H62DU5U?;Q*1H-;Z%1#6MK@SK!I*?K MU,)6T.Q&4KJU*1$QT&3VUS39R6H('U*.+^Z,.)D&/ITD(7HXX%8@.8BD&5(#R'!63.T!P<\#L;I'6G6F@DS@LU[HRGZA)E99*QU6UA7L5AAS^G- MP6H2Y<5;`U(%*]*#':(HLT0BR_U0XX%;ENO5`S]^52J=T=3\UE"XE(F6R26U MG"Y(_+$Z`G"="0J>'EE6N"@E$1CL*`,S(2P?`.,8^'`KT*J.J:V;GAHKJL:] M@+3(CO<2!KA4+C<6;GU1[7V7KO")B;4"9S.]E^Q[CPC%Z7W.O;\.!CG]T+4W MTO;_`+K^N_H=GI>C^"E:^EZ?3IZ?I_3/9V=/T=.G`K$^UEURM2++(/95#4]. MX>O?CY4KC4JK>(/;,=*51)*=3)\H%[0>G#(U"=,66-<'&%0BP!#DS.,8QP+H MJRG:EHZ+$P>F:R@540X@\Q47%Z[B3%#6+"LT(`G+!MD?0H$AJT\)8?4.&$1H M^F.X6>!1[BU\HG85C31J]Z;K&XV%":8H;VJS(/&YJD;E!OI^JH;2Y`W+_ER@ MW!(<"&1DL8L!QC.KPT1]"WH1+%&"P^H=D&3#.W'<+/3@9$X'JZ/,C/9S//(KN:1-YE)Y+C_Y0*N!+UXY.:X\7ZI*1$F&8+/Z`ASP,;T'>$-V-J"&75`DTB01>:H% MJI*TR]G%'Y:Q+6EU<&%\C\H81GJ1LTA87QJ4I%B;)@\E'DB#W9Z=>!:+'M+6 M<@K[7*RD!$IQ'=HG^*QRM`*&<@IR(<)A"I//6D4H28<1@:$P6.)*L'#+,49` M?DL&,"P+(@AFZ4R`Z--93D1'9%*1FO,=:,M<62H5CH46_OS:QG/)I+@XM:<+ M-'2G#*]Q,P;DTI`F.&66<8$)0P^8W+8U,4KDMB[VWOJ1GD4BB3FI;5`5)*&2 MQ)X5Q^3,B@8/N@<&-[0'I5)?VE'E"!GXASP*#9ED1ZJ(J&82@#D8TCE5?0_` M6E(!:L^;65/XS6\=%D@9Z8.$8)#+$HE)G=U)38,,P$60X#D,5(]JJQ75S`[1 M((E7TU8MT)J'CX!LR<+H";JK8>*:*-<4?S'($K#]7LAPLJ0F#'A%D)OI]<]F M`V4X&+IM;\/K^9UE!I&-P(=;75S-)&UA*4HQH1Y@<-H>C&FM:KMDJ0)"2S(N]0JY3YT5! MW!B=0'C$O&M+KU<<8')0`@),($$0_4S@`4*W[X;*I>X)#$$&GEIV/969*HB- M>UTFC67M4QPM*VJ9?*G1VFLGAD/C\:CPWQN3G*%KD2(U8Y)2"`&FFX#@+FIV MV(Y=U?MM@1IND;*C6N4FC[I')DT98I9%Y3"Y*[PR8Q62M/KK"4KQ')0PJT9^ M2#U"4X1/J)SCB!EFC#)7MT_^H)_V0/\`1X'[<#"-RWFRTZ;`V;,4F=BSNT)& MMC%?5U7Z5@/DTB7-+$XR9^7B5RR0Q.*L4?CK$UFJ%R]Q028 M%:IBWHY>,!13^,MTB8B#'J619ZC,P;26B61*7P.4O$)F<4DC<086:,,J%\#J7CX M!_O01%-V"R?CRD^,8@173[P3&SQ,KE"X. M9TS@)\,DJDKK^L2JL>:*"#,=/AD)A)H18S^G&>!EO?;ZQDM+M5)5\R%2"7;% MV+$:CPWKG1R8&/Z&.-63>W_J62-3%)5D<8W"H86^-V5@4*G(5:X@L)8QF!#D M+6U$_$R$7!M74-H0V-PHY_ET=V5@+?"I2_SJ&@8+D;%4?GC6URI[A$"&8YI+ M;KEX>5R/Y>6)-]2$BP(P!H1<#0V%SMBDNN>@>NL>4."F^=?WI>?<]:%M#P7+ M:E*IK6B^(3+W6JE=@MNYM,(7R33)6H,.4N2[+%0LKCF MS(@*Q"3D@"6&/%L2K.#R0B%&,U.0*M&W:WR`YN1KN*#3534J:7.$])>-;1SU MJC3G&"OFSK4"]]4PM6O.,;C"!BRC[EPD>0AYB!HB6(RPL]PK)Y-K_0S+Q>GZ M\R";1&?L%DO%-MDPU]52!X:HRY+GYWC\=1RA-)SIF2O5J#$YP?4>S,G>VS@, MOQ&FYF@HK6N;'61=ZQ,+R-(G$VFUZ6(XKUG0';P6#DIQ"W$5NFGR9M1IQ@<2 MCE#T,G`A!-&(9&<`R&MME& MLDJG>\-AHIB;V\IQ?8QE_*3&)F7'=P,LU=#D$TE**'-S1' MIS6!FT6W#+'D,`KR9Q:F5<6DOCU@*Q2DKJ*RAZE7L("^V`ZN62#$B\UJCST/P#`6!%*KKAXUQL*=U_"SOJ&J/'CHZMKESC;=)&IP@UX1:87\X3Q7'4 M20")0VV:48$K6SDA:*RV6/-)+0,OA@W5SD32]1!E6/#37KP-M,>$XV]2L083#"88<42:&@ M96+.V$0*+%&[S2W;&A^F_D*7T!.T30..9D4^A^S3W!]>;':8[$6N+P9;8:J$ ML[JEBD[@T[U[6+F#5R#2S0]\MR0LN)6B@4> ML$;GL*P35UF!JP`0IYIQZQ`C6XQY$$T'>`,52Z3TU+GVRW"W5L MH<&^3Z_^020T(F=R)\C4.$V1:*Y`8W"A!I9`'?*88LM. M<`R9P)-+1D*^K)IX]+FO1:?'V"(PVQ8+<$\?L"RTPNP+$J2*#;E\X=2`&(V! MO>9)#UK?EP4B+1A<52<@1@1J"L"#3[8^U*ZNXRW;+EL7F[`@D6I4W0Z&B>&V M3(G&57DPVU=C`58E(HF@DM4BM"R#6VOWI@$$!3\U' M@&QY=DY*DDK)YF1##5!@/C3K"9`TRY;,U6TB75[0I+K$0XJ9HJF[?8R6>6BW MMBF``4&"R1-"S6QO^HE&V,V+MU_VN[2!04[STYR0'+XRUDMR`;*FR(MB--;"0F& M!M1<29;J):U]W/4,,?D<,H&>TJ\):\C_`,\^GI*5L934EIV4`:V<1AJ!Q5K[ M;!!'IV,)P(S)S0:I.ZG''F&!,10U+MYF,*UR+'J`!@..O`Z3=#*;==>]*]6*6D!`DLEKJB:UCTL3BQ MT$1+R8NW*):4+[>N0210JQU^W/V\#;3@.`X#@.`X#@.`X#@.`X#@6!BM(IBT MA7'A*K^N1P`%:"6^_5>PS%"Y$9*0)?E?J>R]WAX-$/W';ZO9GLZ]OPX%_P#` M4J$Q.7)5?J MC+#@1W<'OZ]@>@7YP+&L"NHQ9S.U,$N(5K&=IF,)G)2!,N4H2%CY7LJ:IK%P MN@4PP?,&M))6-(I-2F=2%&2`A,"('4.0OG@.!#'YI"]%#:+BA6V:M<@LXU_R M7K2NKYOKUWNM%.AJFL)BN+M-GN;)73G!4R[*$VF[$0@JQD$LI\%<-2'\K4NQV< MUB;T?PJ2IT2*E$RKT/E:@\[TN!UN GRAPHIC 8 g24791img06.jpg GRAPHIC begin 644 g24791img06.jpg M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$! M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$" M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,# M`P,#`P,#`P,#_\``$0@`-0#(`P$1``(1`0,1`?_$`'D```$%``,!```````` M```````%!@<("0,$"@$!`0$````````````````````!$```!P`!`P0!`P`& M"P`````!`@,$!08'"``3"1$2%!4A(A87,4%1,GD*(T.S-+4F-K8X>!D1`0$! M``````````````````!!T?_:``P#`0`"$0,1`#\`]_'0'0'0'0'0'08=\L]O MY+RNU^0B-S7D%:<2KO`_A?0-^SZMTJGYG/1VD:7:J[M=X?'UMQH%.M[8D#8[-+*\N><9_<)%%NWD+72:I97Z#0#@U0>3L$ MPE'2+8%#'4!NFNZ,4GN,)O:`>HB/0/;H&#J=;N5QS:]53.]"[%59N&J& MG,ZY$7!U0;%(,%FT3;&]5GS$A+"M!/%"."LW8@W<"3V''VB/0.F"9R,="0\? M+RQY^68Q4>SE)U1FWCU)J1:M$4'LL=@T$6K$\BY(9844_P#1I"?VE_`!T&=U M'LW(#<=CYSYE7]V>YDVQ#E7QW84:4:T&G6M2/S$F(X1JNC9H#.5;,RKMM)=S MDLT4E'"CA_&%DA4;&#LI)E#2;H#H*4<,-5O^IN>7A+Y8#SY,UYK[5E5(`[", M8?1T"JQ5%<0%?)]8S9B](P6EW!@<..ZZ4[GZU#`!?0,VJ]RAY0.[5G/(9QN4 MXO5;[Y8+OP4>\=E*AG14CI5&I)Z?_)K5]26\XK+J3YVRRZR MK0696WM`H;^=`=!3KR#[E=>-/"/E!O.;_5!?LNQVWVFG+3;+[**:6)HP,E%/ MWT<*B1)!&/=KE7[!S`FL*8$/^DP]!!/%^T;=1N6MJXXZ)O=UY!5"1X@X[R+C M;!IE;S:&MMX MO^07,XC@3R8820JIQ=?T$%KDOQZL,RY06270K.E-+Q/T>0.!T2(OG\4/<**@ M]!7/D7I6X9WO?)5UG6\:31:'Q6U7Q84?+\9KXU'^,7%9WN]UK/M2A[@QDZM) M62PQ\W5984FZ82;?X+E(KE(>Z`"`.Y+;=\+R^:W4VXW\]9=^4V5X.GQ4Q:K_ M``\3$FG#Q;5T'*<$%:"Q%T,N@H@_&;^U[IB"+84_C>B8!5BK\H>5[#'M9UQU MR"U"=E-<\=7DJY#%;2K6JJ5/)=8XZ[T#2+UEE_\`(U9<\LK^ MJ3S[R;>-NG/).-*T.NXJ][JG"JGW&$4!XV=)?#L-7FG;)<0*"@(KF]AB']#` M'WF7J>\<;MJYB2>1\B-CF&6=^.3<.2TA5[[(TZVT?/=4T#2VM:PS]EPA:;&K MQ3*I1]*M:S5H^F\LO'1DE+U MRTO*?*;75*/RQ=X2EK;&+MR%/8Q*C\0M\H,0Z<1BZT5\ST2$2I(@F%U/%_`/ M*K`\UZW(6>?NCN#\A/(>-4M=J-&J6:=3;P^<`V>SZT/'Q,8ZE@:"FFLNBU;@ MX.F*IB`K*WFIPML/GODIYLZ?2@FF@.PKF@5#DYJ"M9M<8 M`F**$Q#J.U>PJ'Y)W#?V]!2CC7O7)^,HK^Y7'?M>N$_LOB/V[F%-15_&NF94 M#=*KIPZM(@XZ*LID2Q(]]H)6[=0Y#*%.=0'7H]UY(IY)Q&JJ7 M+;=X^=O'CZY/%V[W9A$1K M^R5FWYU=HN.;S,(27;NV;NH6^.O!;S6>^@LS$DXD82J^Q0O0(EPT[D93(W9. M/->Y.:^/[&\I'#7CA4MBL`T:Q[#'9)N](PVV7JNR$V]IA*[8%DY.^RA6#I[% MJKMT54B'%4J)`$)1?[;O-2T"Q8FCK-QE)&%\M?&S&(>7F#0[VP../EBXVYAN MM@IDB["(13=L+`RA9WY;GME`4/4TN0-^SVWY5X?LYYQ.$*/%TV%B]%WZ5N:L++.=2AI:J2Q M9NG/(ZMBD>#;_!:D,^<'*!5`0,B%JY7=M^#G(O*I;1>T*[$^13)N(ZF%H)UD MV6A@^@<$U-T5L4C7QK:EG_=\EI_==-+">4*'9;_$3**)3IB&[G0'0'0'0'0' M08B\OI*;UR%\U6.7N7A;%S++3[=67D`:;F72=42EHU0J$B`&,Z;F!$.V'B_$M?>,RD M!*JS]Y\?7D_VQI:$UV00C"*S+8+I3G\&Z;&4"0/)RCG2D%D#D(*)4VJ@'$#& M(`@@\V(DVD.]T7N,]/;?)EVKXS5!H0J`)CZF$)4W__`*C\B'^*WXKO]AP6Z#M\E0_D'#O/ MWN0'%1B-<3XNU=P(@91*&XXX/'2%D(T4$!]B)-4UZPIF`/QWFY@'U$H]`D:Q M5<[H4?R-I-=G=OO.CP?/OQ'.-:TK:[E7K<]NDA.:)QYF*:6N?00%;)%1M:J+ MI"/6(LV*=5=$3@)@'U$-(/'A_O?/7_$9Y%_\$S3H,YL?TV_YE@^9'H-JDZL: M]^>S:LWN7UGQO^8Z%:.4&Y#8JI(_);N!^KF/@(@MV^VJ()A[3E_/J%;..<(1 M>GO-=EYBVVG3.0/@PY3:OKESNETM=QE[7=YO2JVNZ?D_YEX?9+4N/DG:67AX_;/&IQ^T2_I,#E1&4OU!Y42.:5JXD`Q#I)S[*DS!6'?$A MA.BR;%,!BHE``>E]K.=4>PVNCU*9VBXW:K^93QW--=T;:[=`VV9OMM?5S!)> M$DX-6`A*\A%PD/17\7%_'4:IJ"NQ4/\`DIRB(2Y;8T"^72OT%8IC-[-KF2\G MC(>@>PQ:?PAY1XD#X2B/Z@2F(V-()O3\&`O]?IT$'<H]!&/*&_97RILMKY-WD=ZIF)V' MPN4[<;;E&4W2J52WW:BV;9KK*.\VM,Q(0L]$.4?@NNWZME&I05$P@J)1]`"[ M]EV6%@^=E+U#+X.5K;U/DI4/&IR/A)-5BI$:_#6'CD?DWC.J,09*F%I:<:F9 MU:);+N4_D.8R9DVYA[8,Q3#7#0],H.35IW;]'MD-3Z\T!8!?S#HJ)G;A%HY? M?71+%,%9";F%VK-4R+)FDN\<>P023.;\=!4?"^==8Y#;X[R>@TF80I;;/[U; MFNAV%\E&OYV0IDGBG92B::FU=+)56Q5;<(N38R+IZ@[4+[DE6"!BB80OCT!T M!T!T&?O(3@'$[EP[%.TZ\X-R%XW9W6Y$V?(H8=E_)ZXJ7_5 M6%0DHVD,IBTRSBT$;'CGEC7E5&+1HFW`#E%0QP<.T>,VD[';)2>-N&RT:`MU M(XX4O2*14_X\/"Z"GQ4O[K1,AD962GZ-,V2',SF))R22;1CQFVDT3D!0@=O] M02A<.">;W.1VN2D+;=VRNYQI-%8$$HJV\;0R`M4@(4%X58Q:U.AC3 M#[(JXK.C?*<=E9+U3[8,.(\=D.A3.2.16;D#L%PPKDXYW^5N64OXG)8M*$LG M(BV2EOM=GKU]A,Y8:*>7@Y":<)Q82$F^:I(BF15%8$DP*'6_^;]:E,UV6LW3 M>-AN>J;3I&+ZU-[V]:9I#W*!O/',U'/B3^NU2OT.,S5%A3S9['F<-7,0Y)+' M.Y%T)^\`)A8[C%QLC^,]:T2&;Z%=M0FM4V"Y;==;C?DZLWFI&ZWMK!H3H-V= M-KM7K\=#E/!D%JV09D*W3-VP$2E+Z!7>,\;=!C-3C+677M:<9%!H+5LEDLK^:0@%)LT:E+.!5]HHE(W*#7R+Q99 MUDT?8(?^<=PO$,\XK:'PUIL3;'&=$99OA]\L"5A3CJX%52T^D8A5('9=8RJ7Q+"K=QH972FI9_)3=MQ31:C M2Z=H%7L3"Z4JS0#>4GV5`C'*$HP:M'D<[1,=`P$.9/H+#W;C'E=]XQ2G$>99 MS*&02>2,\7*WC9A9M8XVHQE>:UN'7C9U9-RJG.P[1@@L@Y535#Y*)3J$.'N* M(55D/&E5-`8[>OR!WW;-XNVV8C!<>5[_`&!/,Z7,43,JS9WEYA6]-B(MZ9$T>OGKE1IT%3X"E-ZW08U@LV8,472H%56%QWE1,`3-*\4:1 M+\P*MS*<3UF3O=4Q.5Q%G5$CQ`4UU%25F)&BS3AK-'ED7;)$Y'A6X- M71P,D)O0P!`\QXY*@%"SJLT+:-7S2Y9/M'(7::)J$&USR(6N/J3++Z[QUK,NRG6=0M4K;*7.OH&><2*#CO34$,8^,C(.4P$H"B* M(2:\\?=&>C75]JK?)1[AR0TK^/7>_5''R85`7\9LU2-HZ#%KGR* M13PJ2BD,C;[A/2"+2/AS2:+.059( MIM>^[64*BH)&[90WI^.H&K/3=.U6:XM*+'Y? M*0,<+=-!B"*R@F]S<6Y0*4_N'VA&\5S;I,S58*5:Q<^WL#E@R?/85> MI6E1G973`YHRZU[-I<6+=G8I6OV<4X\%UC(,Q472,)Q(83%!0@^=N)S"5?;+ M-[Q&66R0]8=1=07JKMS//+-9HZC2B>?L46:BZ+NWQC/1XA1RF!BM2).#G!<2 MMW79"':KY&:K)0<1*6N+AZD]>7VI1$I$O'-C%Y#T";QUGK$U;W:9Z\0R4A!( M'K5"J3$9I^P.F%3N\N_KLRP&5NV95Q MVTSJGW23[SV+9/CQDRDFT^`#CM-9!)9SVR*$/T')5N=T!*VV`@K)GEWJD,]8 MN64U974$^>1S*RA(89%Q[UHHQ*Y*-#>R.V-FXR+CLJIG3(DVY&>4S2#RFA6:PU.<2FI^6;ZK8/VCB45M5NM="@F[-PSM"5>86!HS&!; M)*R;I)-R\35*"1&RH/N'Y:Y'+6*-JRO[S@IB9F&M;B$;'2;!$)2-F/*UB#F* MXW67:B0LQ4Y6YQB$JDI[`:*.1+[C"@Y!$/E&Y<8[HTP>&JKFU.C&A).9CY1] M3I^(@9D\-4ZG>):&B9B39MFCJ;CZM>(QVHAZE`2K*$*8RC9R1$>5$["T^ MLWG?MTFJSAU8?JZ<]7209$=D.F+83'+\QGWP>E1Y291%XFQB,"X M3$A#=Q6T74S&"CB%]3O)A\@T2`RZA2"&^GB[JSYKR4LRA/:Y:4'%+U`RKQ!0 M%V@.930\KPJ(,DN3U341DI?A58EFYBB)56Y"JE]2'*(AM7H^/4#6UZ=_(L"S MMD52)YW9XNLS;5C*5=Y/.("6K;>2F820:.FLFO$QTXZ%G[_0$%U>Z`"(^/MC5DK9M8F[2HOK0\@X]&<4*T;)VVV-KC) M,#`+<7"C%"2:$2;AW`42;![!.8WZ^@9$1P7RZ#5;N8VX:Z2U2D9R.L,F$G9U5922DH[-VN6`H[D6[1LJ)7M::%.O[`(8[SU6`2_@H`@J M<$.2EQ@9>2FH),6L'0XII66<<\E5NXV@"0[: M1_0>03=JIIJ%!UH\/^LN'N^0"0)$6$I0Y]#XET'2IZQRDY9]!90MNEW=GLE'AI>":U63N M#O*W^-'MGOM#ZW?N?18 MF5&S.;M62Q4W"`RHERE;%2[39+)5FDC6I$BKRT3%"8'>(2@R;$A3."MD&X.% M?<"#AW#JKXY89*5-:;39HB.=R+7/JO,2:#N%KD'*YOF6=R;R1`8QO)2UKEH_ M.B@X75='9`5TJ=%NDJLLH<'L^N.7V6C5>5GZ[+OJH MWK]9EW,LJNVA'<5&[!'P3Y1%NV375!@&VS!A`H@)A(V'_4_K#HS/CYQBQRDU M-S]ET^7E;2YD).X/W4[6B/+3-R$=?H<9AZZ:T]LXB#MHG1GR!&42:.BC@BU4 M5:*+-R*=!)\=QFJ\1OL%M;!97WQ$;KSI5FZ=.EW3NX:U*T59S)^TH),2QM>PX%5.!PLYT!T!T!T!T!T!T!T!T&)'E@1X-Y,DLI,'6M3F>)+UHNEN-":U%E2"3,(:0=`=`=`=`=`=`=`=`=`=`=`=`=`=`=`=`=`=`=`=` '=`=`=!__V3\_ ` end GRAPHIC 9 g24791img07.jpg GRAPHIC begin 644 g24791img07.jpg M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$! M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$" M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,# M`P,#`P,#`P,#_\``$0@`+0#(`P$1``(1`0,1`?_$`($``0`!!`(#`0`````` M```````'!@@)"@0%`0(+`P$!`````````````````````!````<``0,"`@8& M!PD``````0(#!`4&!P@`$0D2$R$*,105EA?7(C(C%E<:8;8W=[=8&8$F=B<8 M*#AX.1$!`0$```````````````````%!_]H`#`,!``(1`Q$`/P#?XZ!T#H'0 M.@UEOF7^1&]<>L@XIR>#[)I6.2=GUF\QMBD'=-CO M6;=V?W2$4$2E4#N'QZ#$'X:?)'Y`5^2&BE?1'*GR'I%Q64,7($]JBRA4#_OQ M2B_B0?\`%&=:P0E9E,,8'L&^M]Y+X![?KZ"'/)IY%O(E(\Z=`A8*V7S@D@7V5>X&>?MA*?U=@[60R?YD M2*G:C6Y&9Y[-9:\S2T!7"!NI'C-:0;1KR8='E)2.T-Y&UR-:QK!50[V15:LP M$H)@H*ITR'"VCDSN/F>X?C# M/@P)`<2CV"F>.&D>7;%*"DIEHN^C&CH+)=H-111XT;**%%$%"@!?T MA`1`!"9R4#YBT^76K9/WJYX)42F+61.>77VUZA9"(U!X]8621BJ.I=2W.P1, M:YCE^SI@Q<(NDTA5;&62$IQ"1O#MY)O(`ZY2607:7*CR#-_P6M"I,32VJ/`L M.8;510)HYATZ<;5TR<*4XL`]LX.N\H`D[D]P.@CGRK>2?R!MN9][^K6KE/P< M:EIV=J?].Q]I`W[L?[M)"I8.^=3;JJ]K9V^N=D3BKW']KV/\`"D[DC\P#G^7 MQ^UVO1><#'*)5.DK1EZ8;U^\<-(-M(E(6$HCMF%9O\R_<,K1+6-@@U6*B*0G M=IB8Q2F[@%.)M1BKYR/V7F7D=2G+"WJD-,63D*FX+*V)TQ?R:46P8 M0.@3$JY6"/BW"QSE0%))-,1.8OA;_-G9G/'IM1-&:S MR6FWG0;S41LKR&13J8NJZQ2GW#AZ60`WU=4&Q@1/\1,7Z>@VQ?\`76\3O^<> MG?)W_./3ON/KWY>=`_UUO$[_`)QZ=]Q]>_+SH*EI?FF\8.AW M&IT"F\LJG.7"\V6"I]4A$*;JC=:8LEEDVL-!Q:+A[0VS)!60DWJ213K*II%$ MX"8Q2]Q`,HW0.@=`Z!T&IE\V!_8GPV_OET7_``^1Z#'S\K*'_??MO]'%*PB/ M]'_-G*@^/^T>@@3SB?\`VVN7_$G$7^IV9]!MX>4+7-0RRT^-EEFUZLM):Z9Y M(<#SG04*X_.P)0B!%Q(7W`3-"Y.I[7N=O5[0JD*82]^W<`'H,F>8MM!V3P(4" ML^/&?&/V-_Q!H=,SAW3;7&TJ;A=.A&$!&:7$M[0X>Q[6J7-.8:3*)W"R[91) M^I[@J$,8%.@H/S-L+W%>"R:BM2E0G=.BJ5Q-C-(F@DT9K[6O\=?,K97*1-,- MA%O*'>61%RH9P3]%83>L/@/01G\N[*4!]XHM,A:,RD9G2(F_;K^)];H4VS@- M.E+)*Q(+TE.)EQ>,'$)-3=')&M8.056111E> M1WE7F]//9WQI(:U0:U(5@E>I<,"A0*SKD&1XJ5JU*'MHE4$"@`#VZ#5\^6A( M5/R;Z\FF0I$TN/NRIID(4"D333US,B)D(4H`4A"%````^`!\.@MV^8N,4GE6 MV(YQ`I"YEAYC&,(`4I2T%J)C"(_````^(]!M1>'^/M/&WQ*Y',\X[;!Q%'!5 MO;J:RT-@0$T=.(Q5^P06,B8PD%5$ANWH.M!Y\5.[N<^ML9?J(O:N1.^SBM-O,*1=.'N-94?YRL:&LL6 M1TJ#=XAZ%T04-Z3!W'H*0U_P$^8WD&E`(;QS&RW9D*HK(KU='3MPV^Z)UY>8 M39I2RT,2=S-X6.4DTX]`JXI>D501(!N_I#L&8GA'X6J!F'%!WC6\UV3S?99> M*DZY>M9XF\JN1U5::*1P=P2,OKB`"5IM9AKJA%J)-G**T*_9**(>X7NDI["8 M25Y,.`O(#D%PASG@5P^_"RIYE7FN9P]BM6Q7JVI3"=,R$D>>I5>+;0='M3B9 ME).3A&+F0DW;A`?2W,4J:AUQ.D&!?'OE[/+CQZLKBXX1RNQG'K0\9ECW\WG6 MP[+5W:3DDC&M>0 M'-7,MB80S@7D1$W[;=HFX*+>B0R0OF%?4RTD&U?^TX== MD'@/\R7'UI.L,'YE9AC3&T.F3ZR-,RW+<*8VGWL<@JVCW;(9`]A MN$\G'9P@64LLX=LF+MXL!EUQ(7UF'L'01GE_R\'EFQ"U/;UC7*7%,INLE'/H MB1MN?;!LU3L3Z*E'K61DHUW+P^7M7J[%_(,45UDC'$JBJ1#"'0N]V&IO#P[M!]$"Y@9 M'.%HU4(MZU25;@*8@DHF0Q0`2@(!Z:%X./-OK=)4S35.=-(TG.U319U:/>N0 M6\6BJJ*0:R+B%5/"S&;NV0K1*[*GWUT[\ MI>@?RN?D#_BCQ4^^NG?E+T#^5S\@?\4>*GWUT[\I>@?RN?D#_BCQ4^^NG?E+ MT$S<*0=Y>&[\.*E#,<;R+";.G59"9KDL\ M>Z3I,M6^4N&91-N)6R^RR0J]2GZ]:95'[.C4"O03=`)Y`3%`"AE/\/Z9"<>+ MTJ!>ZSW1,WD7S@XF4=/Y)_PZXJNY"3D'2@G7&GV(7]:HK7U.K]UOM$]/0F4:^K/!^R]CZD297(W_7]8G'X% M[`(@'"K6GT&XN(]K6K-'RSB5KB5NCTVX.2"ZKB\LX@495,5T$B^PI+M5&X`( M@<3E_5[=A$.^B;/`39WB$;)MU7<>J1&0CU@492L>=9T\9M1?Q3Y-M),DI!9@ ML+4ZJ12.DR>XB)TQ`PA1TQL^75^5M<',7*+8RU'K$M<[8R4*\.K"5B";0SR7 MF'8I-5$Q;,&U@9F4`@G.`+E[%$0,`!)"CEND0ZBBR92D%0IA]8#V,DF990G8 M!$1.1(@F$H?'L`CVZ"A:UJV41A7)'ZI M`(`M#BVL;%44%O;<`DZ3.*8%-WZ#B0.PYW9KE+T&$GSO+-"%G1>(&A9]I%+G MJTA&Q-J;P]E>Q;>M6!W5968:M91%@[)93=[G3Q3"1N M1C8J0GI9PE%5J-F)0T?#0<4Y>/77L_5V;5`ZJQR$#OT%>MWC1V@DZ:N6[ALN MFDJBNBJ11)5-=$CA`Z9R&$IBJMU"G*(?20P"'P'H/U%9$H&,95,"E(54QA4* M`%3/ZO0H81'L!#^D>P_0/8>@]P,41,4#`)B]O44!`1+W#N'J#Z0[AT'GH'0. M@=`Z!T#H'0.@=`Z#Y^&3(+-?,=Y"WKA,Z+:-V>SIO55"B0C<[WGMQ[6;E5,8 M``@G:LUEOCV_9(G-^J4P@VC:[\0[1RVXY6XSA$Z7N:!1FQ/642]UH#BKQJJL MJF'?X^IG.P+INH'TE51,4?B`]!=$OQ^NRO()'>0T8`4;V]%%.E&B8P880EBR"=II2RLB\^N6&8`DE%V.1>J2.BBRE5Y48*;?.WU-86MHM%J)N M&3\CD%RMWK#LFN8/,9X_9YPG=1L4]46#B9RBR4"*5IZ8NFUNT19'TF MZ!V>A?TD]\B@53-\5-&L5O19R5KKHY0RTFTZ"K"'F+<^"V'M&Z06VLFT]G[I`*3 M&R]*>!+L6LDBLY6DT72/U@B1$Q3Z""YSA#ML-0[BRKEAHJ[B8HD?!N:Q`NK/ M'IKR%%@J09E-U\5RQ[5:VZW/TY=>9%VJU3:KR`',Z>J%575"X*N\==5I];ID MO3%LK@KS6KMI%G8TM4MD#+JS%Z343UQ2*A5&4>E*+#!2J"$L=$&;1%^NL[0] M;<52NRA&9.!ECE9=9Y<)_/YELBBNB;M#2RIK=.+:7&F69BX[-6-XDZ_(+ M0:P)G>F39()$*[.@8&Z`1XEP2UAZ[M\>DKF,9%Q]KD6D=)231RX?Z'1I6FX^ MUC:RM]:A+-'UFLT*1IZWV5ZV;TZ;E!0C=LR]P'YPK`.#]XK;.@#'V1A(V%U, MQ5:TV>@DGK%U8Z-8KG;'>F*V!Y(223R0!SF%@4BF*IS.735\1N*902`?2&4W MH'0.@=`Z!T#H'0.@=`Z#5(YI1_"E[SF)S$*GS;1K^>5^[9D[MK MBJV0AWK]RGI^?WZ.T6)S8)M2:;1R+J.D(T9%-DNRL0+JF#8&X0ESDG&RBDS- M:T.(PDA=BVIQ>FT$ROB^I%O-B#65KJSJ[M_5VEB5T4)(RJ44NM#IIB0L
-----END PRIVACY-ENHANCED MESSAGE-----